| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | IRF2BP1 PPRC1 BCOR EZH2 PHF1 WIZ MAP3K10 FOXO4 BSN NCOA2 TCF7L2 WWP2 PPP1R13B SALL4 RELA TACC2 E4F1 AR TBX18 ARRB1 MTOR DDX20 SPEN EP300 SMAD3 CRTC2 HR | 7.28e-06 | 753 | 278 | 27 | GO:0008134 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.04e-05 | 83 | 278 | 8 | GO:1990841 | |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 3.17e-05 | 27 | 278 | 5 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 3.81e-05 | 28 | 278 | 5 | GO:0099602 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.69e-05 | 120 | 278 | 9 | GO:0008013 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 1.93e-04 | 2 | 278 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | protein kinase binding | ATG13 INSR AP1B1 PXN SPDYE21 MAPRE2 SPDYE2B SPDYE1 TCF7L2 ANK2 GIT1 RELA SPDYE18 RGS14 MAPRE3 ARRB1 CD6 MTOR SPDYE2 PAM SCRIB MAP2K1 EP300 SPDYE6 SMAD3 SPDYE16 | 2.31e-04 | 873 | 278 | 26 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | CHIA ATG13 INSR AP1B1 PXN SPDYE21 MAPRE2 SPDYE2B SPDYE1 TCF7L2 ANK2 GIT1 RELA SPDYE18 RGS14 MAPRE3 ARRB1 CD6 MTOR SPDYE2 PAM SCRIB MAP2K1 EP300 SPDYE6 SMAD3 SPDYE16 | 4.98e-04 | 969 | 278 | 27 | GO:0019900 |
| GeneOntologyMolecularFunction | insulin receptor activity | 5.74e-04 | 3 | 278 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TRPS1 IRF3 EVX1 ZNF395 NR6A1 BCOR EZH2 RXRG WIZ GLIS2 FOXO4 KLF17 HSF4 NCOA2 TCF7L2 AIRE SALL4 RELA CHD7 E4F1 DMBX1 AR HIVEP3 TBX18 ZNF750 ZBTB45 NACC2 MTF1 ZNF341 ZNF335 ZSCAN5C HSFX1 ZFHX3 ZNF79 EP300 SMAD3 | 5.86e-04 | 1459 | 278 | 36 | GO:0000977 |
| GeneOntologyMolecularFunction | molecular adaptor activity | IRF2BP1 PPRC1 DAB2 ATG2A SRCAP BCOR EZH2 RXRG NUFIP1 KMT2C FAF2 BASP1 PXN MAP3K10 IRF2BPL MICAL3 POLK BAG6 SPPL2C MRTFA NCOA2 ANK2 AR RGS14 ARRB1 EIF4G1 SUN5 DDX20 EIF3B SCRIB MAP2K1 SPEN EP300 HR | 6.35e-04 | 1356 | 278 | 34 | GO:0060090 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | TRPS1 IRF3 KLF17 HSF4 RELA E4F1 DMBX1 TBX18 ZNF750 ZBTB45 NACC2 ZFHX3 SMAD3 | 6.92e-04 | 326 | 278 | 13 | GO:0001217 |
| GeneOntologyMolecularFunction | chromatin binding | IRF3 CHD3 EZH2 REPIN1 PHF1 MLLT6 FOXO4 NCOA2 TCF7L2 AIRE RELA CHD7 AR PHC1 ZNF750 KMT5B DPPA4 STAG3 EP300 SMAD3 CRTC2 HR | 7.07e-04 | 739 | 278 | 22 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 7.82e-04 | 140 | 278 | 8 | GO:0001221 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | IRF3 EVX1 ZNF395 NR6A1 EZH2 RXRG WIZ GLIS2 FOXO4 KLF17 HSF4 NCOA2 TCF7L2 SALL4 RELA CHD7 E4F1 AR HIVEP3 TBX18 ZNF750 ZBTB45 NACC2 MTF1 ZNF341 MTOR ZNF335 ZSCAN5C HSFX1 ZFHX3 EP300 SMAD3 | 8.61e-04 | 1271 | 278 | 32 | GO:0000987 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | 5.42e-08 | 28 | 268 | 7 | GO:1904031 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 6.55e-07 | 25 | 268 | 6 | GO:0045737 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | IRF2BP1 USP9X TRPS1 DAB2 IRF3 CHD3 NR6A1 BCOR EZH2 ZNF469 GLIS2 IRF2BPL KLF17 HSF4 FOXG1 NCOA2 TCF7L2 WWP2 SALL4 RELA E4F1 DMBX1 AR TBX18 ZNF750 ZBTB45 NACC2 ZFHX3 DDX20 SPEN EP300 INS-IGF2 SMAD3 | 2.69e-06 | 1053 | 268 | 33 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | IRF2BP1 USP9X TRPS1 DAB2 IRF3 CHD3 NR6A1 BCOR EZH2 ZNF469 BASP1 GLIS2 MAP3K10 IRF2BPL KLF17 HSF4 ZNF282 FOXG1 NCOA2 TCF7L2 WWP2 NELFB SALL4 RELA E4F1 DMBX1 AR PHC1 TBX18 ZNF750 ZBTB45 NACC2 ZFHX3 DDX20 SPEN EP300 INS-IGF2 SMAD3 HR | 5.25e-06 | 1399 | 268 | 39 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | IRF2BP1 USP9X TRPS1 DAB2 IRF3 CHD3 NR6A1 BCOR EZH2 ZNF469 BASP1 GLIS2 MAP3K10 IRF2BPL KLF17 HSF4 ZNF282 FOXG1 NCOA2 TCF7L2 WWP2 NELFB SALL4 RELA E4F1 DMBX1 AR PHC1 TBX18 ZNF750 ZBTB45 NACC2 ZFHX3 DDX20 SPEN EP300 INS-IGF2 SMAD3 HR | 6.63e-06 | 1413 | 268 | 39 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | PPRC1 USP9X APC2 INSR INSRR RGS11 GMIP PPP1R3G ZC4H2 EZH2 TTBK1 NAF1 PXN MAP3K10 MAPRE2 SPDYE2B WNK2 SPDYE1 TCF7L2 ANK2 APOA5 ASAP3 RELA AR ARHGEF15 RGS14 MAPRE3 ARRB1 MTOR EIF4G1 SPDYE2 SCRIB MAP2K1 EP300 INS-IGF2 SPDYE6 SMAD3 CRTC2 SPDYE16 | 8.75e-06 | 1430 | 268 | 39 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 4.85e-05 | 100 | 268 | 8 | GO:1904029 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CATIP CTTNBP2 SPTBN2 INSRR OBSCN ARHGEF11 KCNC3 SCN4A PXN MICAL3 MRTFA ESPN ANK2 PDCD6IP ASAP3 ARHGEF18 ARHGEF15 MYLK2 NUAK2 ELMO3 ARRB1 MTOR KANK3 PAM SNTA1 EP300 SMAD3 | 6.15e-05 | 912 | 268 | 27 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | INSR INSRR DAB2 EZH2 TTBK1 PXN MAP3K10 SPDYE2B VEGFB SPDYE1 AR ARAF MAPRE3 ARRB1 CD6 MTOR EIF4G1 SPDYE2 TNKS1BP1 MAP2K1 EP300 INS-IGF2 SPDYE6 SPDYE16 | 8.91e-05 | 780 | 268 | 24 | GO:0042327 |
| GeneOntologyBiologicalProcess | energy reserve metabolic process | 1.23e-04 | 114 | 268 | 8 | GO:0006112 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PPRC1 DAB2 IRF3 EVX1 ZNF395 NR6A1 RXRG NUFIP1 KMT2C GLIS2 MLLT6 FOXO4 IRF2BPL MRTFA NCOA2 ATMIN FOXN1 TCF7L2 WWP2 AIRE SALL4 RELA CHD7 E4F1 AR IER2 ZNF750 ARRB1 MTF1 ZNF335 ZFHX3 MAP2K1 EP300 SMAD3 CRTC2 | 1.32e-04 | 1390 | 268 | 35 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide catabolic process | 1.66e-04 | 63 | 268 | 6 | GO:0033121 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide catabolic process | 1.66e-04 | 63 | 268 | 6 | GO:0030811 | |
| GeneOntologyBiologicalProcess | regulation of glycolytic process | 1.66e-04 | 63 | 268 | 6 | GO:0006110 | |
| GeneOntologyBiologicalProcess | thymus epithelium morphogenesis | 1.68e-04 | 2 | 268 | 2 | GO:0097536 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 1.68e-04 | 2 | 268 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | regulation of ATP metabolic process | 1.85e-04 | 91 | 268 | 7 | GO:1903578 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 1.97e-04 | 122 | 268 | 8 | GO:0110020 | |
| GeneOntologyBiologicalProcess | insulin receptor signaling pathway | 2.09e-04 | 156 | 268 | 9 | GO:0008286 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | INSR DAB2 EZH2 TTBK1 PXN MAP3K10 SPDYE2B VEGFB SPDYE1 ARAF MAPRE3 ARRB1 CD6 MTOR EIF4G1 SPDYE2 TNKS1BP1 MAP2K1 EP300 INS-IGF2 SPDYE6 SPDYE16 | 2.10e-04 | 724 | 268 | 22 | GO:0001934 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | INSR EZH2 TTBK1 PXN MAP3K10 SPDYE2B SPDYE1 MAPRE3 MTOR SPDYE2 MAP2K1 INS-IGF2 SPDYE6 SPDYE16 | 2.10e-04 | 350 | 268 | 14 | GO:0045860 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | INSR EZH2 MAP3K10 SPDYE2B SPDYE1 MAPRE3 SPDYE2 MAP2K1 SPDYE6 SPDYE16 | 2.25e-04 | 193 | 268 | 10 | GO:0071902 |
| GeneOntologyBiologicalProcess | polysaccharide metabolic process | 2.45e-04 | 126 | 268 | 8 | GO:0005976 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | INSR INSRR PPP1R3G EZH2 TTBK1 NAF1 PXN MAP3K10 SPDYE2B SPDYE1 MAPRE3 MTOR SPDYE2 MAP2K1 INS-IGF2 SPDYE6 SPDYE16 | 2.48e-04 | 490 | 268 | 17 | GO:0051347 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.57e-04 | 96 | 268 | 7 | GO:0000079 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 2.59e-04 | 127 | 268 | 8 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 2.59e-04 | 127 | 268 | 8 | GO:0043149 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | INSR INSRR EZH2 TTBK1 PXN MAP3K10 SPDYE2B SPDYE1 MAPRE3 MTOR SPDYE2 MAP2K1 INS-IGF2 SPDYE6 SPDYE16 | 2.88e-04 | 405 | 268 | 15 | GO:0033674 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | OBSCN PXN PDCD6IP ASAP3 ARHGEF18 ARHGEF15 ARRB1 MTOR KANK3 EP300 SMAD3 | 3.09e-04 | 239 | 268 | 11 | GO:0031032 |
| GeneOntologyBiologicalProcess | glycogen metabolic process | 3.11e-04 | 99 | 268 | 7 | GO:0005977 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | CATIP CTTNBP2 SPTBN2 INSRR OBSCN ARHGEF11 KCNC3 PXN MICAL3 MRTFA ESPN PDCD6IP ASAP3 ARHGEF18 ARHGEF15 NUAK2 ELMO3 ARRB1 MTOR KANK3 PAM EP300 SMAD3 | 3.50e-04 | 803 | 268 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | glucan metabolic process | 3.52e-04 | 101 | 268 | 7 | GO:0044042 | |
| GeneOntologyCellularComponent | nuclear body | CBLL1 OBSCN CHD3 ZNF395 SRCAP IVL BASP1 GLIS2 FOXO4 POLK HSF4 GCNA NCOA2 ATMIN FAM193B TCF7L2 AIRE E4F1 AR PHC1 RGS14 ARRB1 MTOR ZFHX3 DDX20 SNAPC2 HR | 4.72e-05 | 903 | 270 | 27 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | TRPS1 IRF3 EVX1 CHD3 NR6A1 SRCAP EZH2 RXRG NUFIP1 BASP1 CFDP1 FOXO4 KLF17 HSF4 FOXG1 NCOA2 FOXN1 TCF7L2 BICRA CECR2 ADNP2 SALL4 RELA CHD7 DMBX1 AR PHC1 TBX18 ARRB1 NACC2 HSFX1 ZFHX3 TNKS1BP1 STAG3 EP300 SMAD3 HR | 8.57e-05 | 1480 | 270 | 37 | GO:0000785 |
| GeneOntologyCellularComponent | paranodal junction | 3.26e-04 | 11 | 270 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.20e-04 | 75 | 270 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | methyltransferase complex | 5.10e-04 | 108 | 270 | 7 | GO:0034708 | |
| Domain | Spy1 | 3.92e-09 | 11 | 272 | 6 | PF11357 | |
| Domain | Speedy | 3.92e-09 | 11 | 272 | 6 | IPR020984 | |
| Domain | GOLGA6L | 6.45e-07 | 6 | 272 | 4 | IPR026737 | |
| Domain | fn3 | TSPOAP1 INSR INSRR OBSCN NFASC NEO1 SDK1 ROBO4 COL20A1 IGDCC3 VWA1 CSF3R LRRN4 | 7.49e-07 | 162 | 272 | 13 | PF00041 |
| Domain | FN3 | TSPOAP1 INSR INSRR OBSCN IL20RA NFASC NEO1 SDK1 ROBO4 COL20A1 IGDCC3 VWA1 CSF3R LRRN4 | 1.38e-06 | 199 | 272 | 14 | PS50853 |
| Domain | FN3_dom | TSPOAP1 INSR INSRR OBSCN IL20RA NFASC NEO1 SDK1 ROBO4 COL20A1 IGDCC3 VWA1 CSF3R LRRN4 | 2.46e-06 | 209 | 272 | 14 | IPR003961 |
| Domain | FN3 | TSPOAP1 INSR INSRR OBSCN NFASC NEO1 SDK1 ROBO4 COL20A1 IGDCC3 VWA1 CSF3R LRRN4 | 3.33e-06 | 185 | 272 | 13 | SM00060 |
| Domain | Ubiquitin-rel_dom | FAF2 UBAC1 HERPUD2 BAG6 RALGDS PPP1R13B ARAF RGS14 RADIL UBQLN3 PLCE1 | 8.37e-05 | 184 | 272 | 11 | IPR029071 |
| Domain | PHD | 1.10e-04 | 75 | 272 | 7 | PF00628 | |
| Domain | GOLGA2L5 | 1.15e-04 | 18 | 272 | 4 | PF15070 | |
| Domain | Golgin_A | 1.15e-04 | 18 | 272 | 4 | IPR024858 | |
| Domain | Znf_PHD-finger | 1.52e-04 | 79 | 272 | 7 | IPR019787 | |
| Domain | DUOX1 | 2.11e-04 | 2 | 272 | 2 | IPR029595 | |
| Domain | PHD | 3.20e-04 | 89 | 272 | 7 | SM00249 | |
| Domain | Znf_PHD | 3.67e-04 | 91 | 272 | 7 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.77e-04 | 95 | 272 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 5.08e-04 | 96 | 272 | 7 | PS01359 | |
| Domain | BAT2_N | 6.28e-04 | 3 | 272 | 2 | PF07001 | |
| Domain | EB1_C | 6.28e-04 | 3 | 272 | 2 | IPR004953 | |
| Domain | Interferon_reg_fac2-bd1_2_Znf | 6.28e-04 | 3 | 272 | 2 | IPR022750 | |
| Domain | EB1_C | 6.28e-04 | 3 | 272 | 2 | PS51230 | |
| Domain | IRF-2BP1_2 | 6.28e-04 | 3 | 272 | 2 | PF11261 | |
| Domain | EB1 | 6.28e-04 | 3 | 272 | 2 | PF03271 | |
| Domain | BAT2_N | 6.28e-04 | 3 | 272 | 2 | IPR009738 | |
| Domain | IER | 6.28e-04 | 3 | 272 | 2 | PF05760 | |
| Domain | IER | 6.28e-04 | 3 | 272 | 2 | IPR008653 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 6.28e-04 | 3 | 272 | 2 | IPR016246 | |
| Domain | MAPRE | 6.28e-04 | 3 | 272 | 2 | IPR027328 | |
| Domain | PRRC2 | 6.28e-04 | 3 | 272 | 2 | IPR033184 | |
| Domain | Znf_C2H2-like | CBLL1 TRPS1 ZNF395 GPATCH8 REPIN1 NUFIP1 ZNF469 WIZ GLIS2 KLF17 ZNF282 ATMIN ADNP2 SALL4 E4F1 HIVEP3 ZNF750 ZBTB45 MTF1 ZNF341 ZNF335 ZSCAN5C ZFHX3 ZNF79 | 6.34e-04 | 796 | 272 | 24 | IPR015880 |
| Domain | ZnF_C2H2 | CBLL1 TRPS1 ZNF395 GPATCH8 REPIN1 NUFIP1 ZNF469 WIZ GLIS2 KLF17 ZNF282 ATMIN ADNP2 SALL4 E4F1 HIVEP3 ZNF750 ZBTB45 MTF1 ZNF341 ZNF335 ZSCAN5C ZFHX3 ZNF79 | 7.81e-04 | 808 | 272 | 24 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | CBLL1 TRPS1 ZNF395 GPATCH8 REPIN1 NUFIP1 ZNF469 WIZ GLIS2 KLF17 ZNF282 ATMIN ADNP2 SALL4 E4F1 HIVEP3 ZBTB45 MTF1 ZNF341 ZNF335 ZSCAN5C ZFHX3 ZNF79 | 1.01e-03 | 775 | 272 | 23 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | CBLL1 TRPS1 ZNF395 GPATCH8 REPIN1 NUFIP1 ZNF469 WIZ GLIS2 KLF17 ZNF282 ATMIN ADNP2 SALL4 E4F1 HIVEP3 ZBTB45 MTF1 ZNF341 ZNF335 ZSCAN5C ZFHX3 ZNF79 | 1.05e-03 | 777 | 272 | 23 | PS00028 |
| Domain | ZnF_C2HC | 1.21e-03 | 55 | 272 | 5 | SM00343 | |
| Domain | Znf_CCHC | 1.21e-03 | 55 | 272 | 5 | IPR001878 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 2.46e-07 | 89 | 185 | 10 | M39732 | |
| Pathway | KEGG_PROSTATE_CANCER | 2.16e-05 | 89 | 185 | 8 | M13191 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 4.70e-05 | 73 | 185 | 7 | M39758 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | ATG13 RPS6KB1 PAK4 INSR PAK6 EZH2 KMT2C MAP3K10 VEGFB TCF7L2 FRAT1 PHC1 CDH24 MTOR EIF4G1 MAP2K1 ULK2 | 6.74e-05 | 439 | 185 | 17 | M42563 |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 7.49e-05 | 7 | 185 | 3 | MM15661 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 9.81e-05 | 57 | 185 | 6 | M19888 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.08e-04 | 58 | 185 | 6 | MM15602 | |
| Pathway | WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION | 1.19e-04 | 8 | 185 | 3 | M39537 | |
| Pathway | WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION | 1.19e-04 | 8 | 185 | 3 | M39447 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.19e-04 | 59 | 185 | 6 | M41812 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 1.44e-04 | 21 | 185 | 4 | MM1464 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.57e-04 | 62 | 185 | 6 | M14631 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.75e-04 | 22 | 185 | 4 | MM15656 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 1.75e-04 | 22 | 185 | 4 | M17294 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 2.63e-04 | 68 | 185 | 6 | M48322 | |
| Pathway | PID_MTOR_4PATHWAY | 2.84e-04 | 69 | 185 | 6 | M121 | |
| Pathway | SIG_CHEMOTAXIS | 2.94e-04 | 45 | 185 | 5 | M5193 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 3.08e-04 | 70 | 185 | 6 | M13266 | |
| Pathway | KEGG_PANCREATIC_CANCER | 3.08e-04 | 70 | 185 | 6 | M9726 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | APC2 RXRG VEGFB RALGDS TCF7L2 RELA AR ARAF CSF3R MTOR MAP2K1 EP300 SMAD3 | 3.63e-04 | 325 | 185 | 13 | M12868 |
| Pathway | WP_CANCER_PATHWAYS | RPS6KB1 APC2 ARHGEF11 RXRG POLK VEGFB RALGDS TCF7L2 FRAT1 RELA AR ARAF CSF3R MTOR MAP2K1 EP300 SMAD3 | 3.74e-04 | 507 | 185 | 17 | M48302 |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 5.11e-04 | 213 | 185 | 10 | M18306 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TPRA1 KMT2B KIAA0513 PPRC1 OBSCN ZNF395 ATG2A SRCAP ARHGEF11 REPIN1 DUS1L CDR2L KMT2C WIZ IER5L SEC16A PXN KCTD15 MLLT6 MICAL3 WNK2 PRRC2B ATMIN FAM193B BICRA MEX3D NLRX1 ADGRL1 MIB2 PLCD3 HIVEP3 RADIL MROH6 ADAMTS7 ZNF341 MTOR ZNF335 KANK3 EIF4G1 DISP2 TNKS1BP1 ARRDC2 SPEN ULK2 EP300 HR | 1.53e-19 | 1105 | 287 | 46 | 35748872 |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A1 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 3.67e-15 | 25 | 287 | 10 | 17684299 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.16e-13 | 23 | 287 | 9 | 18602769 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSPOAP1 APC2 DAB2 ATG2A IVL ZNF469 POM121 FAF2 MLLT6 IRF2BPL BSN WNK2 MRTFA TCF7L2 PDCD6IP BICRA PPFIBP2 ASAP3 ARHGEF18 CHD7 DPPA4 UBQLN3 SPEN CRTC2 | 2.56e-13 | 430 | 287 | 24 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES ATG13 PAK4 CBARP PAK6 CDR2L SEC16A SIK2 MAP3K10 FOXO4 BICC1 PDCD6IP GIT1 KIF26B WWP2 RALGPS2 NELFB CCDC85C ARAF MYLK2 NUAK2 RADIL MTOR PLEKHG3 EIF4G1 TNKS1BP1 USP54 SCRIB MAP2K1 CRTC2 | 4.09e-11 | 861 | 287 | 30 | 36931259 |
| Pubmed | SPTBN2 PAK4 DAB2 PAK6 ARHGEF11 CCDC88B KMT2C POM121 MAP3K10 WNK2 RALGDS PDCD6IP KIF26B BICRA ADNP2 PPP1R13B ADGRL1 RELA ARAF ARRB1 MAP2K1 EP300 | 1.50e-10 | 486 | 287 | 22 | 20936779 | |
| Pubmed | TRPS1 IRF3 CHD3 NR6A1 SRCAP NUFIP1 PHF1 WIZ GLIS2 PXN MLLT6 KLF17 ZNF282 MRTFA NCOA2 TCF7L2 AIRE SALL4 RELA DMBX1 PHC1 HIVEP3 ZNF750 PRICKLE3 MTF1 ZSCAN5C ZFHX3 SMAD3 | 2.15e-10 | 808 | 287 | 28 | 20412781 | |
| Pubmed | CBLL1 NES CTTNBP2 USP9X RPS6KB1 SPTBN2 APC2 NFASC BCOR ARHGEF11 WIZ AP1B1 BASP1 SEC16A BSN PRRC2A FOXG1 WNK2 PRRC2B NCOA2 ANK2 PDCD6IP GIT1 ARHGEF18 CHD7 HNRNPUL2 MTOR EIF4G1 DCHS1 SCRIB | 5.90e-10 | 963 | 287 | 30 | 28671696 | |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 4.53e-09 | 9 | 287 | 5 | 36272447 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TRPS1 BCOR EZH2 KMT2C WIZ PIP4K2A SEC16A NCOA2 TCF7L2 PDCD6IP BICRA CECR2 ADNP2 CHD7 FAM90A1 DDX20 USP54 EP300 | 7.42e-09 | 398 | 287 | 18 | 35016035 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B DAB2 CHD3 GPATCH8 BCOR EZH2 NAF1 SEC16A IRF2BPL MICAL3 PRRC2A BAG6 MRTFA GIT1 NELFB CHD7 TUBGCP6 PRICKLE3 ZNF335 EIF4G1 TNKS1BP1 DDX20 EIF3B SCRIB SPEN | 8.48e-09 | 774 | 287 | 25 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TPRA1 MARS1 ATG13 RPS6KB1 INSR TRPS1 OBSCN NFASC CHD3 ZC4H2 KMT2C SCNN1A MICAL3 SEMA6A HSD11B2 POLK WNK2 ESPN NCOA2 ATMIN TCF7L2 PDCD6IP NEIL1 BICRA PPFIBP2 WWP2 CCDC85C ARHGEF18 ADGRL1 AR HIVEP3 ARRB1 NACC2 PLEKHG3 ZFHX3 EP300 | 9.01e-09 | 1489 | 287 | 36 | 28611215 |
| Pubmed | KIAA0513 TSPOAP1 PPRC1 ATG13 GPATCH8 UNC5A FAF2 SEC16A MICAL3 PRRC2B ATMIN ADGRL1 PPIP5K1 DISP2 SCRIB SPEN ULK2 PLCE1 | 1.05e-08 | 407 | 287 | 18 | 12693553 | |
| Pubmed | KMT2B IRF2BP1 MARS1 USP9X TRPS1 IRF3 CHD3 GPATCH8 SRCAP BCOR KMT2C WIZ BASP1 CFDP1 SEC16A KCTD15 MLLT6 IRF2BPL UQCRC2 PRRC2A PRRC2B NCOA2 TCF7L2 BICRA CCDC85C PPP1R13B RELA CHD7 HNRNPUL2 EIF4G1 ZFHX3 EIF3B USP54 SPEN EP300 | 1.07e-08 | 1429 | 287 | 35 | 35140242 | |
| Pubmed | 3.02e-08 | 83 | 287 | 9 | 28794006 | ||
| Pubmed | PPRC1 MARS1 ATG13 RPS6KB1 PAK4 OBSCN CD55 CHD3 GPATCH8 SRCAP BCOR REPIN1 KMT2C MFAP2 SEC16A POLK BICC1 MRTFA NCOA2 PDCD6IP RALGPS2 ARHGEF18 SALL4 TACC2 CHD7 ZNF750 ZNF341 ULK2 SZRD1 | 3.33e-08 | 1084 | 287 | 29 | 11544199 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 4.51e-08 | 13 | 287 | 5 | 15611625 | |
| Pubmed | USP9X RPS6KB1 DAB2 EZH2 SEC16A PXN PRRC2A BAG6 MRTFA WWP2 NELFB TACC2 ARAF HNRNPUL2 EIF4G1 TNKS1BP1 DDX20 SCRIB SPEN | 5.01e-08 | 503 | 287 | 19 | 16964243 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 HSD11B2 RALGPS2 FAM90A1 KANK3 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A10 | 1.34e-07 | 164 | 287 | 11 | 22967998 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRPS1 IRF3 EVX1 ZNF395 NR6A1 EZH2 RXRG FOXO4 HSF4 ZNF282 FOXG1 FOXN1 TCF7L2 ADNP2 AIRE RELA E4F1 DMBX1 AR HIVEP3 TBX18 MTF1 ZNF335 ZFHX3 SMAD3 | 1.82e-07 | 908 | 287 | 25 | 19274049 |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 2.11e-07 | 17 | 287 | 5 | 15574121 | |
| Pubmed | USP9X ATG13 GPATCH8 BCOR EZH2 CDAN1 BAG6 CECR2 SALL4 CHD7 PDCD7 PHC1 HNRNPUL2 DPPA4 DDX20 SPEN | 2.38e-07 | 396 | 287 | 16 | 26687479 | |
| Pubmed | NES CTTNBP2 MARS1 USP9X SPTBN2 NFASC CHD3 ARHGEF11 LACTB AP1B1 PIP4K2A SEC16A MICAL3 UQCRC2 BSN VPS51 PRRC2A WNK2 PRRC2B ANK2 PDCD6IP GIT1 ADGRL1 NUAK2 MAPRE3 HNRNPUL2 EIF4G1 TNKS1BP1 USP54 SCRIB MAP2K1 SNTA1 | 3.68e-07 | 1431 | 287 | 32 | 37142655 | |
| Pubmed | RPS6KB1 CHD3 GMIP EZH2 AP1B1 SIK2 MICAL3 UQCRC2 PRRC2B RALGDS MIB2 RGS3 ARAF PLCD3 HNRNPUL2 PAM SCRIB CRTC2 PLCE1 HR | 5.88e-07 | 650 | 287 | 20 | 38777146 | |
| Pubmed | KMT2B IRF2BP1 DAB2 CHD3 AP1B1 UBAC1 CFDP1 SDK1 BAG6 PDCD6IP WWP2 PPP1R13B E4F1 PDCD7 RGS3 PLCD3 ZNF341 EIF4G1 SMAD3 | 5.90e-07 | 591 | 287 | 19 | 15231748 | |
| Pubmed | TRPS1 EMILIN3 CHD3 SRCAP BCOR BOD1L2 REPIN1 NUFIP1 ZNF469 WIZ NAF1 PIP4K2A SEC16A VPS51 PRRC2B P3H3 BICRA CECR2 ADNP2 ARAF TUBGCP6 KMT5B ZFHX3 USP54 SCRIB EP300 ALG13 | 7.25e-07 | 1116 | 287 | 27 | 31753913 | |
| Pubmed | CTTNBP2 USP9X PAK4 AP1B1 BASP1 SEC16A RALGPS2 NELFB CCDC85C PPP1R13B ARAF RADIL USP54 MAP2K1 CRTC2 ALG13 | 1.14e-06 | 446 | 287 | 16 | 24255178 | |
| Pubmed | PPRC1 RPS6KB1 INSR INSRR RXRG SCNN1A NCOA2 APOA5 RELA MTOR MAP2K1 EP300 | 1.32e-06 | 250 | 287 | 12 | 18660489 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B TRPS1 BCOR KMT2C WIZ SEC16A PRRC2B NCOA2 TCF7L2 BICRA CHD7 ZFHX3 SPEN EP300 | 1.58e-06 | 351 | 287 | 14 | 38297188 |
| Pubmed | 2.21e-06 | 4 | 287 | 3 | 20448036 | ||
| Pubmed | CBLL1 KMT2B MARS1 TRPS1 CD55 GPATCH8 BCOR EZH2 ARHGEF11 REPIN1 KMT2C WIZ PXN UQCRC2 PRRC2A RELA CHD7 E4F1 PDCD7 ARAF MYLK2 PLCD3 RBM22 ARRB1 CGREF1 PLEKHG3 EIF4G1 ZFHX3 DDX20 EIF3B SPEN | 2.79e-06 | 1497 | 287 | 31 | 31527615 | |
| Pubmed | ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. | 3.06e-06 | 13 | 287 | 4 | 21795849 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.77e-06 | 146 | 287 | 9 | 23892456 | |
| Pubmed | KMT2B USP9X SPTBN2 SRCAP BCOR KMT2C WIZ SEC16A PRRC2A PRRC2B NCOA2 CCDC85C PPP1R13B TNKS1BP1 SCRIB SPEN EP300 | 3.85e-06 | 549 | 287 | 17 | 38280479 | |
| Pubmed | KMT2B DAB2 NFASC ZC4H2 ARHGEF11 WNK2 ANK2 BICRA NELFB AIRE PRICKLE3 SPEN SMAD3 | 4.13e-06 | 329 | 287 | 13 | 17474147 | |
| Pubmed | USP9X TRPS1 CHD3 DUS1L SEC16A IRF2BPL PRRC2A PRRC2B EIF4G1 TNKS1BP1 EIF3B SCRIB EP300 | 4.56e-06 | 332 | 287 | 13 | 37433992 | |
| Pubmed | IRF2BP1 IRF3 IRF2BPL PRRC2A BAG6 PRRC2B NLRX1 RELA MIB2 RGS3 ARAF EP300 | 4.75e-06 | 283 | 287 | 12 | 21903422 | |
| Pubmed | Selective gene activation by spatial segregation of insulin receptor B signaling. | 5.49e-06 | 5 | 287 | 3 | 17264162 | |
| Pubmed | One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. | 5.49e-06 | 5 | 287 | 3 | 15315758 | |
| Pubmed | 5.49e-06 | 5 | 287 | 3 | 12672795 | ||
| Pubmed | The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis. | 5.49e-06 | 5 | 287 | 3 | 27203176 | |
| Pubmed | CBARP KL BASP1 MICAL3 BSN PRRC2A ANK2 GIT1 ADGRL1 MAPRE3 RADIL TNKS1BP1 SNTA1 | 7.33e-06 | 347 | 287 | 13 | 17114649 | |
| Pubmed | 7.64e-06 | 57 | 287 | 6 | 18022353 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP9X SRCAP BCOR PIP4K2A SEC16A BSN POLK PRRC2B NCOA2 GIT1 PPP1R13B TACC2 CHD7 RBM22 TNKS1BP1 DDX20 SPEN | 9.43e-06 | 588 | 287 | 17 | 38580884 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | RPS6KB1 SPTBN2 TRPS1 DAB2 IRF3 PHF1 AP1B1 BASP1 POLK MAPRE2 PRRC2A MRTFA GIT1 NEIL1 MIB2 ARRB1 PRICKLE3 EIF4G1 ZNF79 EIF3B SPDYE16 ALG13 | 1.05e-05 | 925 | 287 | 22 | 28986522 |
| Pubmed | 1.09e-05 | 6 | 287 | 3 | 29706626 | ||
| Pubmed | 1.09e-05 | 6 | 287 | 3 | 22711699 | ||
| Pubmed | ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. | 1.09e-05 | 6 | 287 | 3 | 19225151 | |
| Pubmed | Steroid and oxygen effects on eIF4F complex, mTOR, and ENaC translation in fetal lung epithelia. | 1.09e-05 | 6 | 287 | 3 | 17556672 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.09e-05 | 6 | 287 | 3 | 23728480 | |
| Pubmed | KMT2B TRPS1 CHD3 BCOR WIZ SEC16A PXN MRTFA CCDC85C CHD7 ARAF PHC1 ZFHX3 TNKS1BP1 | 1.16e-05 | 418 | 287 | 14 | 34709266 | |
| Pubmed | KMT2B DAB2 GPATCH8 BCOR POM121 MLLT6 PRRC2A BAG6 WNK2 PRRC2B FAM193B WWP2 RADIL HSFX1 USP54 SPEN ALG13 | 1.45e-05 | 608 | 287 | 17 | 16713569 | |
| Pubmed | 1.48e-05 | 38 | 287 | 5 | 33283408 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | IRF2BP1 TRPS1 IRF3 EZH2 RXRG PHF1 FOXG1 MRTFA NCOA2 NELFB SALL4 RELA E4F1 AR TBX18 PRICKLE3 MTF1 SPEN EP300 SMAD3 HR | 1.51e-05 | 877 | 287 | 21 | 20211142 |
| Pubmed | USP9X APC2 NFASC LACTB AP1B1 MAPRE2 GIT1 ADGRL1 MIB2 ARAF MAPRE3 PAM MAP2K1 SNTA1 | 1.59e-05 | 430 | 287 | 14 | 32581705 | |
| Pubmed | S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. | 1.90e-05 | 7 | 287 | 3 | 17053147 | |
| Pubmed | SNX4 TRPS1 LACTB NUFIP1 PHF1 COLEC12 KMT2C NAF1 MLLT6 IRF2BPL PRRC2B KIF26B NELFB ADNP2 PDCD7 PHC1 ZNF335 SMAD3 | 2.00e-05 | 689 | 287 | 18 | 36543142 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | USP9X PAK4 DAB2 IRF3 ATG2A GMIP NUFIP1 AP1B1 NAF1 SEC16A SIK2 PXN MRTFA MEX3D CCDC85C RELA ARAF MROH6 PRICKLE3 MTOR TNKS1BP1 SNAPC2 CRTC2 | 2.02e-05 | 1038 | 287 | 23 | 26673895 |
| Pubmed | PPRC1 USP9X SPTBN2 APC2 TRPS1 RXRG NUFIP1 WIZ MAP3K10 HERPUD2 PIP4P2 PRRC2A NCOA2 ANK2 GIT1 ADNP2 AIRE PDCD7 SLC4A3 RBM22 ARRB1 EIF4G1 USP54 SCRIB SNTA1 EP300 | 2.74e-05 | 1285 | 287 | 26 | 35914814 | |
| Pubmed | TRPS1 RXRG PHF1 KMT2C PXN FOXO4 KLF17 FOXG1 NCOA2 TCF7L2 TACC2 E4F1 DMBX1 PHC1 RBM22 PRICKLE3 MTF1 ZFHX3 | 2.91e-05 | 709 | 287 | 18 | 22988430 | |
| Pubmed | CBLL1 FAM114A1 CTTNBP2 OBSCN GPATCH8 EZH2 REPIN1 IER5L BASP1 KCTD15 MICAL3 PHF21B PRRC2B NCOA2 FAM193B ANK2 SALL4 TACC2 PHC1 TUBGCP6 RADIL PLEKHG3 USP54 EP300 INS-IGF2 | 2.99e-05 | 1215 | 287 | 25 | 15146197 | |
| Pubmed | 3.02e-05 | 8 | 287 | 3 | 17043309 | ||
| Pubmed | 3.02e-05 | 8 | 287 | 3 | 21460630 | ||
| Pubmed | 3.02e-05 | 8 | 287 | 3 | 12082103 | ||
| Pubmed | mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. | 3.02e-05 | 8 | 287 | 3 | 16541103 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIAA0513 TRPS1 IRF3 LACTB WIZ CFDP1 FOXO4 FOXG1 NCOA2 FOXN1 RELA E4F1 RBM22 NACC2 HNRNPUL2 EIF4G1 SCRIB SPEN EP300 SMAD3 | 3.46e-05 | 857 | 287 | 20 | 25609649 |
| Pubmed | NES KMT2B KCNV2 RPS6KB1 IRF3 NR6A1 COG6 GLIS2 KCTD15 PCSK1N BSN PRRC2B ROBO4 RALGDS TCF7L2 ADNP2 TACC2 ARAF PHC1 PLCD3 HNRNPUL2 PPIP5K1 | 3.73e-05 | 1006 | 287 | 22 | 15226823 | |
| Pubmed | SUSD6 PAK4 NFASC ATG2A BCOR ZC4H2 KMT2C BSN WNK2 RALGDS PDCD6IP CECR2 NUAK2 TUBGCP6 TNKS1BP1 | 3.94e-05 | 529 | 287 | 15 | 14621295 | |
| Pubmed | SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. | 4.50e-05 | 9 | 287 | 3 | 18423201 | |
| Pubmed | Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. | 5.01e-05 | 25 | 287 | 4 | 23906066 | |
| Pubmed | 5.16e-05 | 157 | 287 | 8 | 30186101 | ||
| Pubmed | 5.24e-05 | 49 | 287 | 5 | 34368113 | ||
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | KMT2B IRF3 CHD3 EZH2 KCTD15 MRTFA P3H3 RELA FAM90A1 APOBEC4 MYLK2 SLC6A13 | 5.70e-05 | 364 | 287 | 12 | 31391242 |
| Pubmed | IRF-7 is the master regulator of type-I interferon-dependent immune responses. | 6.39e-05 | 10 | 287 | 3 | 15800576 | |
| Pubmed | 6.39e-05 | 10 | 287 | 3 | 16286006 | ||
| Pubmed | Human ALKBH4 interacts with proteins associated with transcription. | 6.39e-05 | 10 | 287 | 3 | 23145062 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 6.79e-05 | 2 | 287 | 2 | 28633507 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 26061549 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 16310047 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 9111344 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 18511699 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 15659381 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 34953044 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 25600244 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 16407298 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 15760907 | ||
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 6.79e-05 | 2 | 287 | 2 | 22523549 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 6.79e-05 | 2 | 287 | 2 | 23281318 | |
| Pubmed | Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. | 6.79e-05 | 2 | 287 | 2 | 15963500 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 14625312 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 11038184 | ||
| Pubmed | EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis. | 6.79e-05 | 2 | 287 | 2 | 35085106 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 24675012 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 27864353 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 9717843 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 9233623 | ||
| Pubmed | Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. | 6.79e-05 | 2 | 287 | 2 | 25061101 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 25820700 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 23362256 | ||
| Pubmed | Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. | 6.79e-05 | 2 | 287 | 2 | 15899889 | |
| Interaction | TOP3B interactions | TPRA1 KMT2B KIAA0513 PPRC1 SPTBN2 OBSCN ZNF395 ATG2A SRCAP ARHGEF11 REPIN1 DUS1L CDR2L KMT2C WIZ IER5L SEC16A PXN KCTD15 MLLT6 MICAL3 PRRC2A WNK2 PRRC2B ATMIN FAM193B PDCD6IP BICRA MEX3D NLRX1 ADGRL1 MIB2 PLCD3 HIVEP3 RADIL MROH6 ADAMTS7 ZNF341 MTOR ZNF335 KANK3 EIF4G1 DISP2 TNKS1BP1 DDX20 ARRDC2 SPEN ULK2 EP300 HR | 1.09e-09 | 1470 | 272 | 50 | int:TOP3B |
| Interaction | TPRX1 interactions | 7.47e-09 | 21 | 272 | 7 | int:TPRX1 | |
| Interaction | TLX3 interactions | TRPS1 BCOR KMT2C PRR20C PRR20D PRR20B WIZ PRR20E NCOA2 TCF7L2 PRR20A CHD7 AR TBX18 ZFHX3 GOLGA6L9 SNTA1 EP300 | 9.57e-08 | 291 | 272 | 18 | int:TLX3 |
| Interaction | ZNF683 interactions | 1.03e-07 | 10 | 272 | 5 | int:ZNF683 | |
| Interaction | SOX7 interactions | 1.55e-07 | 82 | 272 | 10 | int:SOX7 | |
| Interaction | CELF4 interactions | 1.87e-07 | 11 | 272 | 5 | int:CELF4 | |
| Interaction | HNF4A interactions | KMT2B IRF2BP1 TRPS1 CHD3 SRCAP BCOR EZH2 KMT2C WIZ NCOA2 TCF7L2 BICRA CHD7 AR SPEN EP300 SMAD3 | 2.21e-07 | 275 | 272 | 17 | int:HNF4A |
| Interaction | SH3RF1 interactions | PRR20C PRR20D PRR20B PRR20E NAF1 PXN MAP3K10 SEMA6A PDCD6IP PRR20A ARHGEF15 | 2.40e-07 | 108 | 272 | 11 | int:SH3RF1 |
| Interaction | BEND2 interactions | 3.16e-07 | 12 | 272 | 5 | int:BEND2 | |
| Interaction | ZCCHC14 interactions | 5.50e-07 | 37 | 272 | 7 | int:ZCCHC14 | |
| Interaction | EGR2 interactions | TRPS1 BCOR KMT2C WIZ SEC16A PRRC2B NCOA2 TCF7L2 BICRA WWP2 CHD7 ZFHX3 EP300 | 5.98e-07 | 171 | 272 | 13 | int:EGR2 |
| Interaction | FEV interactions | KMT2B TRPS1 GPATCH8 BCOR KMT2C WIZ KCTD15 PRRC2B NCOA2 TCF7L2 BICRA CHD7 ZFHX3 EP300 | 7.19e-07 | 203 | 272 | 14 | int:FEV |
| Interaction | PTTG2 interactions | 7.82e-07 | 14 | 272 | 5 | int:PTTG2 | |
| Interaction | YWHAH interactions | NES ATG13 PAK4 CBARP ZNF395 PAK6 CDR2L BASP1 SEC16A SIK2 MAP3K10 FOXO4 BICC1 WNK2 NCOA2 PDCD6IP GIT1 KIF26B PPFIBP2 MEX3D RALGPS2 NELFB CCDC85C ARAF NUAK2 RADIL ARRB1 PRICKLE3 MTOR PLEKHG3 EIF4G1 TNKS1BP1 USP54 SCRIB MAP2K1 CRTC2 | 8.37e-07 | 1102 | 272 | 36 | int:YWHAH |
| Interaction | YWHAZ interactions | ATG13 SPTBN2 PAK4 CBARP ZNF395 PAK6 BCOR EZH2 CDR2L SIK2 MAP3K10 FOXO4 UQCRC2 PRRC2A WNK2 GIT1 KIF26B PPFIBP2 WWP2 RALGPS2 NELFB CCDC85C ARHGEF18 TACC2 RGS3 AR ARAF MYLK2 NUAK2 RADIL ARRB1 KMT5B PRICKLE3 MTOR PLEKHG3 USP54 SCRIB MAP2K1 EP300 CRTC2 | 1.27e-06 | 1319 | 272 | 40 | int:YWHAZ |
| Interaction | MBNL3 interactions | 1.67e-06 | 16 | 272 | 5 | int:MBNL3 | |
| Interaction | HNF1B interactions | TRPS1 BCOR KMT2C WIZ MLLT6 PRRC2B NCOA2 TCF7L2 BICRA CHD7 ZFHX3 USP54 EP300 | 1.97e-06 | 190 | 272 | 13 | int:HNF1B |
| Interaction | CRX interactions | TRPS1 BOD1L2 KMT2C WIZ GLIS2 MLLT6 PRRC2B NCOA2 TCF7L2 BICRA CHD7 ZFHX3 SPEN EP300 SMAD3 | 2.04e-06 | 254 | 272 | 15 | int:CRX |
| Interaction | FOXH1 interactions | RXRG PRR20C PRR20D PRR20B PRR20E HSF4 FOXG1 PRR20A SCRIB SMAD3 | 2.24e-06 | 109 | 272 | 10 | int:FOXH1 |
| Interaction | NFIX interactions | KMT2B IRF2BP1 TRPS1 SRCAP BCOR KMT2C WIZ UQCRC2 FOXN1 TCF7L2 BICRA AR ZFHX3 SPEN | 2.71e-06 | 227 | 272 | 14 | int:NFIX |
| Interaction | MAGED1 interactions | USP9X EZH2 PHF1 UNC5A PRR20C PRR20D PRR20B POM121 FAF2 PRR20E NAF1 PRRC2A BAG6 PRR20A AR EP300 | 2.81e-06 | 295 | 272 | 16 | int:MAGED1 |
| Interaction | FAM168A interactions | USP9X PRR20C PRR20D PRR20B PRR20E UBAC1 NAF1 WWP2 CCDC85C PRR20A HR | 3.70e-06 | 142 | 272 | 11 | int:FAM168A |
| Interaction | TLE3 interactions | CBLL1 TRPS1 GPATCH8 BCOR POM121 MLLT6 FOXG1 NCOA2 TCF7L2 CECR2 AR RBM22 ZFHX3 TNKS1BP1 SPEN EP300 CRTC2 ALG13 | 3.92e-06 | 376 | 272 | 18 | int:TLE3 |
| Interaction | ZNF385C interactions | 4.66e-06 | 33 | 272 | 6 | int:ZNF385C | |
| Interaction | HDAC2 interactions | MARS1 TRPS1 CD55 IRF3 CHD3 EZH2 REPIN1 PHF1 WIZ FOXG1 PHF21B TCF7L2 GIT1 WWP2 AIRE SALL4 RELA AR PHC1 NACC2 TNKS1BP1 DDX20 EIF3B ARRDC2 MAP2K1 SPEN EP300 CRTC2 HR | 6.53e-06 | 865 | 272 | 29 | int:HDAC2 |
| Interaction | PRR34 interactions | 7.36e-06 | 21 | 272 | 5 | int:PRR34 | |
| Interaction | PRR20E interactions | 9.21e-06 | 101 | 272 | 9 | int:PRR20E | |
| Interaction | ESRP1 interactions | 9.35e-06 | 77 | 272 | 8 | int:ESRP1 | |
| Interaction | PAX6 interactions | TRPS1 CHD3 SRCAP BCOR KMT2C WIZ KCNC3 MLLT6 PRRC2B TCF7L2 BICRA CHD7 RGS3 AR ZFHX3 EP300 SMAD3 | 1.08e-05 | 366 | 272 | 17 | int:PAX6 |
| Interaction | KLF8 interactions | KMT2B TRPS1 BCOR WIZ SEC16A PRRC2A PRRC2B NCOA2 TCF7L2 BICRA CHD7 HNRNPUL2 EIF4G1 EIF3B SPEN EP300 | 1.12e-05 | 329 | 272 | 16 | int:KLF8 |
| Interaction | CTBP1 interactions | RPS6KB1 TRPS1 CHD3 BCOR EZH2 WIZ GLIS2 SEC16A HSD11B2 VPS51 BAG6 PRRC2B TCF7L2 AR ZNF750 RBM22 SPEN EP300 | 1.12e-05 | 406 | 272 | 18 | int:CTBP1 |
| Interaction | FMR1 interactions | CBLL1 USP9X APC2 CHD3 EZH2 NUFIP1 PHF1 BSN PRRC2A PRRC2B NCOA2 GIT1 CECR2 WWP2 ARHGEF18 TACC2 CHD7 CD6 EIF4G1 SCRIB ALG13 | 1.37e-05 | 536 | 272 | 21 | int:FMR1 |
| Interaction | PATZ1 interactions | CHD3 PHF1 PRR20C PRR20D PRR20B PRR20E WWP2 PRR20A AR SCRIB GOLGA6L9 | 1.39e-05 | 163 | 272 | 11 | int:PATZ1 |
| Interaction | FAM9A interactions | 1.42e-05 | 59 | 272 | 7 | int:FAM9A | |
| Interaction | TBX6 interactions | 1.73e-05 | 41 | 272 | 6 | int:TBX6 | |
| Interaction | SP7 interactions | KMT2B IRF2BP1 TRPS1 CHD3 GPATCH8 BCOR KMT2C WIZ KCTD15 PRRC2B NCOA2 TCF7L2 BICRA CHD7 EP300 | 1.78e-05 | 304 | 272 | 15 | int:SP7 |
| Interaction | GSK3B interactions | MARS1 DAB2 CHD3 ARHGEF11 NUFIP1 AP1B1 BASP1 SEC16A PXN MICAL3 VPS51 BAG6 MRTFA FAM193B PDCD6IP FRAT1 KIF26B RELA AR ARRB1 CSF3R MTOR EIF4G1 TNKS1BP1 DDX20 EIF3B SCRIB SMAD3 | 1.92e-05 | 868 | 272 | 28 | int:GSK3B |
| Interaction | PIN1 interactions | KMT2B RPS6KB1 DAB2 IRF3 CCDC88B WIZ PIP4K2A MLLT6 FOXO4 BAG6 FOXN1 RELA AR ARHGEF15 GOLGA6L9 EP300 SMAD3 | 1.94e-05 | 383 | 272 | 17 | int:PIN1 |
| Interaction | PAX8 interactions | 1.98e-05 | 111 | 272 | 9 | int:PAX8 | |
| Interaction | C3orf36 interactions | 2.25e-05 | 26 | 272 | 5 | int:C3orf36 | |
| Interaction | TBXT interactions | 2.82e-05 | 116 | 272 | 9 | int:TBXT | |
| Interaction | TEAD1 interactions | IRF2BP1 INSR TRPS1 CHD3 BCOR KMT2C WIZ TCF7L2 CHD7 ZFHX3 EP300 | 2.84e-05 | 176 | 272 | 11 | int:TEAD1 |
| Interaction | PRR20B interactions | 2.96e-05 | 90 | 272 | 8 | int:PRR20B | |
| Interaction | PRR20C interactions | 2.96e-05 | 90 | 272 | 8 | int:PRR20C | |
| Interaction | PRR20D interactions | 2.96e-05 | 90 | 272 | 8 | int:PRR20D | |
| Interaction | PPARD interactions | 3.02e-05 | 117 | 272 | 9 | int:PPARD | |
| Interaction | NANOG interactions | KMT2B USP9X GPATCH8 BCOR EZH2 CDAN1 KMT2C WIZ SEC16A CECR2 SALL4 RELA CHD7 PDCD7 ARAF PHC1 HNRNPUL2 DDX20 EP300 | 3.18e-05 | 481 | 272 | 19 | int:NANOG |
| Interaction | POU6F2 interactions | PRR20C PRR20D PRR20B PRR20E UBAC1 GLIS2 PRR20A RELA ZFHX3 GOLGA6L9 | 3.38e-05 | 148 | 272 | 10 | int:POU6F2 |
| Interaction | BHLHE40 interactions | 3.45e-05 | 119 | 272 | 9 | int:BHLHE40 | |
| Interaction | PIP4K2A interactions | PPRC1 RPS6KB1 GPATCH8 NAF1 PIP4K2A FAM90A1 NUAK2 PLCD3 CD6 PRICKLE3 SCRIB SPEN | 3.95e-05 | 216 | 272 | 12 | int:PIP4K2A |
| Interaction | MEX3B interactions | PROSER3 PIP4K2A SEC16A PRRC2A PRRC2B FAM193B GIT1 MEX3D PPP1R13B TNKS1BP1 USP54 ALG13 | 5.16e-05 | 222 | 272 | 12 | int:MEX3B |
| Interaction | ERG interactions | USP9X TRPS1 BCOR KMT2C PRRC2B NCOA2 TCF7L2 BICRA CHD7 AR HNRNPUL2 EP300 | 5.39e-05 | 223 | 272 | 12 | int:ERG |
| Interaction | OXER1 interactions | 5.52e-05 | 50 | 272 | 6 | int:OXER1 | |
| Interaction | DDX20 interactions | USP9X PAK4 NUFIP1 NAF1 SEC16A PXN PRRC2A PDCD6IP PLCD3 MAPRE3 DDX20 ARRDC2 | 5.62e-05 | 224 | 272 | 12 | int:DDX20 |
| Interaction | KRTAP19-5 interactions | 5.89e-05 | 99 | 272 | 8 | int:KRTAP19-5 | |
| Interaction | EIF4ENIF1 interactions | PRR20C PRR20D PRR20B PRR20E SEC16A PRRC2A BICC1 PRRC2B PRR20A RBM22 EIF4G1 EIF3B SMAD3 ALG13 | 6.20e-05 | 300 | 272 | 14 | int:EIF4ENIF1 |
| Interaction | RBPMS interactions | PHF1 PRR20C PRR20D PRR20B POM121 PRR20E GLIS2 PRRC2B NEU4 TCF7L2 PRR20A RBM22 RTP5 SMAD3 ALG13 | 6.43e-05 | 340 | 272 | 15 | int:RBPMS |
| Interaction | TSG101 interactions | CCDC88B SEC16A SCNN1A IRF2BPL PIP4P2 BAG6 PDCD6IP PPFIBP2 WWP2 PPP1R13B CHD7 AR TNKS1BP1 EP300 | 6.90e-05 | 303 | 272 | 14 | int:TSG101 |
| Interaction | NUP35 interactions | IRF2BP1 GPATCH8 GMIP BCOR EZH2 KMT2C POM121 SEC16A BICC1 PRRC2B NCOA2 TCF7L2 PDCD6IP HIVEP3 RBM22 EP300 CRTC2 | 6.93e-05 | 424 | 272 | 17 | int:NUP35 |
| Interaction | KLF5 interactions | TRPS1 BCOR KMT2C SEC16A PRRC2A PRRC2B NCOA2 TCF7L2 AR EP300 SMAD3 | 7.22e-05 | 195 | 272 | 11 | int:KLF5 |
| Interaction | ATXN1 interactions | KMT2B MARS1 USP9X OBSCN GPATCH8 BCOR PRR20C PRR20D PRR20B POM121 AP1B1 BASP1 PRR20E KCTD15 IRF2BPL PRRC2A BAG6 WNK2 PRRC2B FAM193B PDCD6IP PRR20A RELA AR SLC6A13 EIF4G1 HSFX1 USP54 MAP2K1 SPEN | 7.48e-05 | 1039 | 272 | 30 | int:ATXN1 |
| Interaction | CCNK interactions | 7.78e-05 | 132 | 272 | 9 | int:CCNK | |
| Interaction | MYB interactions | 8.25e-05 | 133 | 272 | 9 | int:MYB | |
| Interaction | KLHL12 interactions | 8.36e-05 | 104 | 272 | 8 | int:KLHL12 | |
| Interaction | GATA2 interactions | MARS1 TRPS1 BCOR KMT2C WIZ PRRC2B TCF7L2 PRR20A CHD7 ZFHX3 EP300 | 8.66e-05 | 199 | 272 | 11 | int:GATA2 |
| Interaction | GLIS2 interactions | 9.57e-05 | 106 | 272 | 8 | int:GLIS2 | |
| Interaction | HDAC1 interactions | KMT2B TRPS1 CHD3 ZNF395 BCOR EZH2 REPIN1 PHF1 WIZ PXN HSD11B2 FOXG1 PHF21B MRTFA TCF7L2 WWP2 CCDC85C AIRE SALL4 RELA E4F1 AR ARAF ZNF750 NACC2 ZFHX3 TNKS1BP1 SPEN EP300 SMAD3 HR | 1.00e-04 | 1108 | 272 | 31 | int:HDAC1 |
| Interaction | PRR20A interactions | 1.16e-04 | 109 | 272 | 8 | int:PRR20A | |
| Interaction | YWHAB interactions | ATG13 PAK4 INSR CBARP ZNF395 PAK6 EZH2 CDR2L BASP1 SIK2 MAP3K10 KCTD15 FOXO4 KIF26B RALGPS2 NELFB CCDC85C RGS3 ARAF RADIL ARRB1 PRICKLE3 MTOR PLEKHG3 EIF4G1 USP54 SCRIB MAP2K1 CRTC2 | 1.17e-04 | 1014 | 272 | 29 | int:YWHAB |
| Interaction | PHF1 interactions | CHD3 EZH2 PHF1 PRR20C PRR20D PRR20B PRR20E PRR20A USP54 GOLGA6L9 | 1.20e-04 | 172 | 272 | 10 | int:PHF1 |
| Interaction | PCGF1 interactions | USP9X ATG13 GPATCH8 BCOR EZH2 CDAN1 PDCD7 AR PHC1 DPPA4 ALG13 | 1.28e-04 | 208 | 272 | 11 | int:PCGF1 |
| Interaction | ZBTB32 interactions | 1.29e-04 | 58 | 272 | 6 | int:ZBTB32 | |
| Interaction | PRR35 interactions | 1.31e-04 | 83 | 272 | 7 | int:PRR35 | |
| Interaction | HLX interactions | 1.32e-04 | 37 | 272 | 5 | int:HLX | |
| Interaction | TLX1 interactions | 1.38e-04 | 175 | 272 | 10 | int:TLX1 | |
| Interaction | EP300 interactions | MARS1 USP9X RPS6KB1 IRF3 RGS11 CHD3 NR6A1 SRCAP EZH2 ZNF469 FAF2 AP1B1 CFDP1 SIK2 UQCRC2 BSN VPS51 BAG6 MRTFA NCOA2 ROBO4 TCF7L2 PPP1R13B RELA TACC2 AR ARRB1 MTF1 MTOR EIF3B SCRIB MAP2K1 EP300 SMAD3 CRTC2 ALG13 | 1.49e-04 | 1401 | 272 | 36 | int:EP300 |
| Interaction | TBR1 interactions | 1.50e-04 | 113 | 272 | 8 | int:TBR1 | |
| Interaction | ASF1A interactions | KMT2B SPTBN2 TRPS1 SRCAP BCOR CDAN1 WIZ MLLT6 BICRA CHD7 SPEN EP300 | 1.53e-04 | 249 | 272 | 12 | int:ASF1A |
| Interaction | NCOA6 interactions | 1.60e-04 | 145 | 272 | 9 | int:NCOA6 | |
| Interaction | CABP2 interactions | 1.71e-04 | 61 | 272 | 6 | int:CABP2 | |
| Interaction | YWHAG interactions | ATG13 PAK4 CBARP ZNF395 PAK6 EZH2 CDR2L TTBK1 SEC16A SIK2 MAP3K10 FOXO4 BICC1 PDCD6IP GIT1 KIF26B PPFIBP2 RALGPS2 NELFB CCDC85C ARAF MYLK2 RADIL ARRB1 PRICKLE3 MTOR PLEKHG3 EIF4G1 PPIP5K1 USP54 SCRIB MAP2K1 CRTC2 | 1.71e-04 | 1248 | 272 | 33 | int:YWHAG |
| Interaction | GSC interactions | 1.76e-04 | 87 | 272 | 7 | int:GSC | |
| Interaction | DMRT3 interactions | 1.76e-04 | 87 | 272 | 7 | int:DMRT3 | |
| Interaction | HIVEP1 interactions | 2.27e-04 | 186 | 272 | 10 | int:HIVEP1 | |
| Interaction | PPP1CB interactions | SPTBN2 DAB2 CHD3 EZH2 BASP1 UBAC1 SEC16A SIK2 WWP2 CCDC85C PPP1R13B AR NUAK2 RGS14 PLEKHG3 EIF4G1 SCRIB | 2.31e-04 | 469 | 272 | 17 | int:PPP1CB |
| Interaction | GATA3 interactions | 2.37e-04 | 187 | 272 | 10 | int:GATA3 | |
| Interaction | ATN1 interactions | 2.37e-04 | 187 | 272 | 10 | int:ATN1 | |
| Interaction | PLCD3 interactions | 2.40e-04 | 121 | 272 | 8 | int:PLCD3 | |
| Interaction | C10orf55 interactions | 2.42e-04 | 65 | 272 | 6 | int:C10orf55 | |
| Interaction | FAM222B interactions | 2.44e-04 | 42 | 272 | 5 | int:FAM222B | |
| Interaction | ARRDC3 interactions | USP9X GPATCH8 PHF1 UBAC1 BAG6 PDCD6IP WWP2 FAM90A1 ARRB1 SCRIB SPEN | 2.45e-04 | 224 | 272 | 11 | int:ARRDC3 |
| Interaction | NCOA3 interactions | 2.45e-04 | 224 | 272 | 11 | int:NCOA3 | |
| Interaction | NCK2 interactions | CBARP PRR20C PRR20D PRR20B PRR20E SIK2 PXN SEMA6A PRRC2A GIT1 PRR20A ZNF341 | 2.45e-04 | 262 | 272 | 12 | int:NCK2 |
| Interaction | FOXI1 interactions | 2.49e-04 | 92 | 272 | 7 | int:FOXI1 | |
| Interaction | PHF21A interactions | KMT2B TRPS1 BCOR NAF1 SEC16A PXN VPS51 MRTFA CCDC85C CHD7 AR ARAF ZFHX3 TNKS1BP1 | 2.52e-04 | 343 | 272 | 14 | int:PHF21A |
| Interaction | VSX1 interactions | 2.64e-04 | 66 | 272 | 6 | int:VSX1 | |
| Interaction | NFKBIL1 interactions | 2.66e-04 | 93 | 272 | 7 | int:NFKBIL1 | |
| Interaction | SAMD11 interactions | 2.73e-04 | 43 | 272 | 5 | int:SAMD11 | |
| Interaction | BICRAL interactions | 2.73e-04 | 43 | 272 | 5 | int:BICRAL | |
| Interaction | FOXP3 interactions | PRR20C PRR20D PRR20B WIZ AP1B1 PRR20E IRF2BPL MAPRE2 PRRC2A PDCD6IP PRR20A RELA NACC2 EIF4G1 MAP2K1 EP300 | 2.78e-04 | 432 | 272 | 16 | int:FOXP3 |
| Cytoband | 13q21.1 | 1.12e-08 | 13 | 286 | 5 | 13q21.1 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A2P FAM90A17 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.00e-07 | 154 | 286 | 9 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A2P FAM90A17 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.82e-05 | 234 | 286 | 9 | chr8p23 |
| Cytoband | 11q13 | 1.02e-04 | 118 | 286 | 6 | 11q13 | |
| Cytoband | 15q22.3-q23 | 2.30e-04 | 4 | 286 | 2 | 15q22.3-q23 | |
| Cytoband | 15q15.3 | 4.97e-04 | 25 | 286 | 3 | 15q15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 8.60e-04 | 117 | 286 | 5 | chr13q21 | |
| GeneFamily | Fibronectin type III domain containing | TSPOAP1 INSR INSRR OBSCN NFASC NEO1 SDK1 ROBO4 COL20A1 IGDCC3 VWA1 CSF3R LRRN4 | 6.56e-09 | 160 | 178 | 13 | 555 |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 4.23e-06 | 12 | 178 | 4 | 756 | |
| GeneFamily | PHD finger proteins | 2.99e-05 | 90 | 178 | 7 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | TRPS1 ZNF395 REPIN1 ZNF469 WIZ GLIS2 KLF17 ZNF282 ATMIN ADNP2 SALL4 E4F1 HIVEP3 ZBTB45 ZNF341 ZNF335 ZSCAN5C ZFHX3 ZNF79 | 8.84e-05 | 718 | 178 | 19 | 28 |
| GeneFamily | Ankyrin repeat domain containing | CTTNBP2 BCOR ESPN ANK2 GIT1 ASAP3 PPP1R13B MIB2 KANK3 ANKRD34C | 1.46e-04 | 242 | 178 | 10 | 403 |
| GeneFamily | Autophagy related | 2.97e-04 | 33 | 178 | 4 | 1022 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.34e-04 | 34 | 178 | 4 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.81e-04 | 66 | 178 | 5 | 722 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 178 | 7 | 593 | |
| GeneFamily | Regulators of G-protein signaling | 1.10e-03 | 21 | 178 | 3 | 720 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | SPTBN2 INSR RGS11 ARHGEF11 KL MICAL3 SDK1 WNK2 RALGDS ANK2 GIT1 ADGRL1 SLC4A3 MAPRE3 DCHS1 PPIP5K1 GOLGA6L9 | 2.89e-06 | 429 | 272 | 17 | M45694 |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 8.06e-06 | 199 | 272 | 11 | M3599 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN | SNX4 EZH2 REPIN1 NUFIP1 SIK2 TACC2 ARRB1 GPATCH3 NACC2 KMT5B SCRIB | 8.45e-06 | 200 | 272 | 11 | M8966 |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | APC2 INSR PAK6 BCOR GLIS2 HSD11B2 PPP1R13B ZNF750 ARRB1 GOLGA6L9 HR | 1.17e-05 | 207 | 272 | 11 | M14566 |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN | NES BCOR MICAL3 SLC25A29 MRTFA RALGDS PPP1R13B ARHGEF15 DCHS1 ARRDC2 | 1.56e-05 | 175 | 272 | 10 | M34029 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_664_5P_GENES | 2.75e-05 | 57 | 272 | 6 | MM17505 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME2 | 3.10e-05 | 18 | 272 | 4 | M1952 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME2 | 3.89e-05 | 19 | 272 | 4 | MM831 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 4.70e-05 | 199 | 272 | 10 | M5348 | |
| Coexpression | GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP | ATG13 CHD3 CCDC88B AP1B1 LYPD5 SLC25A29 E4F1 MS4A15 RGS3 ZNF335 | 4.70e-05 | 199 | 272 | 10 | M3073 |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP | TPRA1 SUSD6 PPP1R3G PHF1 IER5L IRF2BPL VEGFB IER2 TNKS1BP1 SMAD3 | 4.90e-05 | 200 | 272 | 10 | M9748 |
| Coexpression | PEREZ_TP53_TARGETS | SUSD6 APC2 INSR OBSCN EMILIN3 BCOR DUOX1 GLIS2 IRF2BPL MICAL3 HSD11B2 PRRC2B ESPN KIF26B DUOX2 MIB2 VWA1 TUBGCP6 ZNF750 CDH24 ARRB1 ADAMTS7 ZNF341 DISP2 GOLGA6L9 LRRC37B SMAD3 HR | 5.90e-05 | 1201 | 272 | 28 | M4391 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | TSPOAP1 SPTBN2 OBSCN RGS11 BASP1 SLC25A29 FAM193B GIT1 PRRT2 PDCD7 SLC4A3 TUBGCP6 ULK2 STAG3 | 6.23e-05 | 389 | 272 | 14 | M39102 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 6.27e-05 | 166 | 272 | 9 | M17163 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 6.56e-05 | 167 | 272 | 9 | MM1057 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | INSRR PHF1 PCSK1N ANK2 ADGRL1 CHD7 IER2 EIF4G1 DISP2 INS-IGF2 | 7.98e-05 | 212 | 272 | 10 | MM3816 |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP | 8.63e-05 | 135 | 272 | 8 | M2916 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | KIAA0513 TSPOAP1 PKHD1 WNK2 VEGFB CECR2 ELMO3 PRICKLE3 ZNF335 GOLGA6L9 | 2.44e-07 | 185 | 275 | 10 | 636505a3d96f75d951ab42bcf8af6ae07abc732d |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | OBSCN MICAL3 MAPRE2 WNK2 ANK2 PPP1R13B TACC2 SLC4A3 RGS3 PAM | 3.28e-07 | 191 | 275 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | USP9X INSRR PGAP6 AP1B1 SEC16A PCSK1N PRRC2B ANK2 EIF4G1 DISP2 | 3.61e-07 | 193 | 275 | 10 | fe451b3295d77b2bd1ac25cf29310c85835a45fe |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | NES INSR PCDH12 SEMA6A ROBO4 VWA1 ARHGEF15 MYLK2 KANK3 DCHS1 | 4.57e-07 | 198 | 275 | 10 | 5e274f29cc796dae7d64d6035e904816c25f9914 |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.58e-07 | 166 | 275 | 9 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.71e-06 | 178 | 275 | 9 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 179 | 275 | 9 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 183 | 275 | 9 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-06 | 183 | 275 | 9 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 98 | 275 | 7 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.68e-06 | 188 | 275 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 188 | 275 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.33e-06 | 193 | 275 | 9 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 193 | 275 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 193 | 275 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 193 | 275 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 193 | 275 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.47e-06 | 194 | 275 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-06 | 196 | 275 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 197 | 275 | 9 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 197 | 275 | 9 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-06 | 197 | 275 | 9 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.93e-06 | 197 | 275 | 9 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 4.10e-06 | 198 | 275 | 9 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 4.10e-06 | 198 | 275 | 9 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 4.27e-06 | 199 | 275 | 9 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-06 | 199 | 275 | 9 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.84e-06 | 156 | 275 | 8 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | Control-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 9.75e-06 | 120 | 275 | 7 | 840d0ac995e2fa41996514753e4e03c4aa4a26d0 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 170 | 275 | 8 | c1f7f1bb8865e954bb499963d82bb51923d5d8d6 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-05 | 172 | 275 | 8 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 125 | 275 | 7 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 1.47e-05 | 177 | 275 | 8 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.49e-05 | 128 | 275 | 7 | 7e3f5cea91af005f08d8e9340fb8630bf1c887c3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.49e-05 | 128 | 275 | 7 | a876303c852db2af9418d1a1711d7c950805018a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.49e-05 | 128 | 275 | 7 | 388062f840fd04cb8087f27a9a78e7a192920e3e | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-05 | 181 | 275 | 8 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 182 | 275 | 8 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 182 | 275 | 8 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 182 | 275 | 8 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 182 | 275 | 8 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 183 | 275 | 8 | a0a3e4d07ac73dbbb1e019fd11e88ccffe6cf2ca | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.87e-05 | 183 | 275 | 8 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | TCGA-Prostate-Primary_Tumor|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.18e-05 | 187 | 275 | 8 | 3e6a95c912dad5d61e10497ffaafd2b9027cd13a | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.18e-05 | 187 | 275 | 8 | 87ecdc5f24aced95a37e653429f0fc493ff4aa3e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.18e-05 | 187 | 275 | 8 | fa0452f3382c22c0391b241d06504fda3c6a19f0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 188 | 275 | 8 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 188 | 275 | 8 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 190 | 275 | 8 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 190 | 275 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 190 | 275 | 8 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.45e-05 | 190 | 275 | 8 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.45e-05 | 190 | 275 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.45e-05 | 190 | 275 | 8 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 190 | 275 | 8 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.45e-05 | 190 | 275 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-05 | 192 | 275 | 8 | 5012cc3ec0766f06af447463413422b484446c43 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 2.64e-05 | 192 | 275 | 8 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 194 | 275 | 8 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.84e-05 | 194 | 275 | 8 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.84e-05 | 194 | 275 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 194 | 275 | 8 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-05 | 194 | 275 | 8 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 195 | 275 | 8 | ea1b00805391dca8be0883b635768b296369919a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 195 | 275 | 8 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.95e-05 | 195 | 275 | 8 | f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 195 | 275 | 8 | 85df110f753f58ab017018c54ee454edb4428e29 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 195 | 275 | 8 | f55ab1018a6cde7d517b53e6ce44c3f7bde485c4 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 195 | 275 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.95e-05 | 195 | 275 | 8 | 13168c9632b58dd65ecb365df3832d95e7325919 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 195 | 275 | 8 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | proximal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.95e-05 | 195 | 275 | 8 | 36b2e754ed7ff138ac05fb51f4494e5339669828 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 196 | 275 | 8 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.06e-05 | 196 | 275 | 8 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-05 | 197 | 275 | 8 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 3.17e-05 | 197 | 275 | 8 | 353b76ca3e2aa4b8f51396e7121c4baa114083a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 198 | 275 | 8 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | mild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.28e-05 | 198 | 275 | 8 | 1d20fc9948965de52a98f758035edfdd12cafc5f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.28e-05 | 198 | 275 | 8 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 198 | 275 | 8 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | severe-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.28e-05 | 198 | 275 | 8 | 6ef22f33b43e9adceea11738e3cba0e8b59b4ec6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.28e-05 | 198 | 275 | 8 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.28e-05 | 198 | 275 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 198 | 275 | 8 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.28e-05 | 198 | 275 | 8 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-05 | 198 | 275 | 8 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.28e-05 | 198 | 275 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-05 | 199 | 275 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 199 | 275 | 8 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 199 | 275 | 8 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 199 | 275 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 199 | 275 | 8 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 199 | 275 | 8 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-05 | 199 | 275 | 8 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | control-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.40e-05 | 199 | 275 | 8 | 8aca7775b3d34fd26c7b23ddb23f5f2df72684b0 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-05 | 199 | 275 | 8 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-05 | 199 | 275 | 8 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | Kidney-Endothelial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.40e-05 | 199 | 275 | 8 | b543f0686522df43737e9ffa5c9733e42b8a9f4d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-05 | 200 | 275 | 8 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-05 | 200 | 275 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | NES IRF2BP1 SUSD6 CHD3 STOML1 SIK2 PXN RALGDS CCDC85C ELMO3 HNRNPUL2 PRICKLE3 CGREF1 ZNF335 STAG3 | 1.31e-08 | 196 | 269 | 15 | 7477_DN |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | IRF2BP1 SPTBN2 GMIP PHF1 WIZ PXN VEGFB ADGRL1 RGS14 CD6 PRICKLE3 CGREF1 ZFHX3 | 5.75e-07 | 194 | 269 | 13 | 4242_DN |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | KMT2B ARHGEF11 PGAP6 PHF1 MICAL3 TCF7L2 PPFIBP2 CCDC85C CD6 PLEKHG3 ZNF335 ZNF79 SNAPC2 | 7.68e-07 | 199 | 269 | 13 | 2404_DN |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | CHD3 AP1B1 PXN MAPRE2 FOXG1 PRRC2B TCF7L2 BICRA CCDC85C ADGRL1 AR ZNF79 SNAPC2 | 7.68e-07 | 199 | 269 | 13 | 7219_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | NES ATG13 CHD3 ARHGEF11 PXN PRRC2A FRAT1 ADGRL1 HNRNPUL2 PRICKLE3 CGREF1 SMAD3 | 4.47e-06 | 198 | 269 | 12 | 5335_DN |
| Drug | fullerene C60 | TSPOAP1 PPRC1 APC2 RGS11 SRCAP ARHGEF11 LACTB MFAP2 AP1B1 IER5L BASP1 GLIS2 SCNN1A MAP3K10 IRF2BPL HSD11B2 BSN ZNF282 PRRC2A PRRC2B VEGFB ESPN FOXN1 APOA5 P3H3 COL20A1 NLRX1 ARHGEF18 PRRT2 RGS3 MYLK2 CD6 KMT5B PRICKLE3 EIF3B ARRDC2 SNTA1 CRTC2 | 7.05e-06 | 1498 | 269 | 38 | ctd:C069837 |
| Drug | oxophenylarsine | 8.93e-06 | 87 | 269 | 8 | ctd:C029341 | |
| Drug | 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one | 1.74e-05 | 14 | 269 | 4 | ctd:C553294 | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | KMT2B MARS1 ATG13 CHD3 MRTFA RALGPS2 ADGRL1 ARRB1 PLEKHG3 SZRD1 SMAD3 | 2.09e-05 | 194 | 269 | 11 | 1699_DN |
| Drug | wortmannin; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | NES KMT2B MARS1 SRCAP ASAP3 ADGRL1 CD6 PRICKLE3 MTOR PLEKHG3 HR | 2.19e-05 | 195 | 269 | 11 | 911_DN |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | KMT2B SRCAP WIZ STOML1 PXN PRRC2B BICRA ELMO3 MTOR STAG3 SZRD1 | 2.19e-05 | 195 | 269 | 11 | 3408_DN |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | ATG13 PCDH12 WIZ VEGFB RALGDS BICRA ASAP3 ARHGEF15 HIVEP3 ELMO3 ZFHX3 | 2.19e-05 | 195 | 269 | 11 | 414_DN |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A | TPRA1 CHD3 SRCAP BCOR SIK2 MAPRE2 MTF1 MTOR SNAPC2 STAG3 SMAD3 | 2.30e-05 | 196 | 269 | 11 | 1678_DN |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | IL20RA PCDH12 SRCAP ZC4H2 HSF4 VEGFB NCOA2 BRME1 ZNF79 ULK2 HR | 2.30e-05 | 196 | 269 | 11 | 3558_UP |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | NES CCNO CHD3 PXN MICAL3 FOXG1 NCOA2 TCF7L2 NLRX1 MTOR STAG3 | 2.41e-05 | 197 | 269 | 11 | 7231_DN |
| Drug | AC1OAGFB | SPTBN2 INSR ZNF395 BASP1 PIP4K2A SCN4A SCNN1A PIP4P2 ESPN GIT1 COL20A1 ASAP3 RELA PLCD3 HNRNPUL2 MTOR SNTA1 CRTC2 PLCE1 | 2.49e-05 | 539 | 269 | 19 | CID006857345 |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A | FAM114A1 ARHGEF11 PGAP6 MICAL3 TCF7L2 GIT1 CCDC85C NUAK2 ELMO3 HNRNPUL2 SNAPC2 | 2.52e-05 | 198 | 269 | 11 | 2381_DN |
| Drug | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone | 8.29e-05 | 61 | 269 | 6 | ctd:C517943 | |
| Drug | sodium arsenite | 8.46e-05 | 152 | 269 | 9 | CID000443495 | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 192 | 269 | 10 | 2873_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.05e-04 | 193 | 269 | 10 | 4202_DN | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | NR6A1 PHF1 WIZ PXN PRRC2A NCOA2 NLRX1 ADAMTS7 HNRNPUL2 SZRD1 | 1.10e-04 | 194 | 269 | 10 | 3481_UP |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | NES ZNF395 PRRC2A TCF7L2 HNRNPUL2 ZNF335 ZNF79 ULK2 STAG3 SMAD3 | 1.10e-04 | 194 | 269 | 10 | 7196_DN |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | KIAA0513 MARS1 CCNO SRCAP PXN PRRC2A TCF7L2 ADGRL1 RGS3 SMAD3 | 1.10e-04 | 194 | 269 | 10 | 990_DN |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; HL60; HT_HG-U133A | KMT2B INSR ZC4H2 ARHGEF11 PGAP6 MAPRE2 MRTFA NCOA2 TCF7L2 ADGRL1 | 1.15e-04 | 195 | 269 | 10 | 2187_DN |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 195 | 269 | 10 | 2230_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.15e-04 | 195 | 269 | 10 | 4969_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.19e-04 | 196 | 269 | 10 | 7226_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.19e-04 | 196 | 269 | 10 | 6889_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A | FAM114A1 SRCAP ZC4H2 CDR2L SIK2 MRTFA PPFIBP2 NUAK2 CD6 SNAPC2 | 1.19e-04 | 196 | 269 | 10 | 2390_DN |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | CHD3 ZNF395 ARHGEF11 PRRC2B RELA HNRNPUL2 PAM ZNF79 EP300 ALG13 | 1.19e-04 | 196 | 269 | 10 | 1843_DN |
| Drug | Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A | CCNO RALGDS TCF7L2 GIT1 RGS3 ELMO3 ARRB1 GPATCH3 ZNF79 SMAD3 | 1.19e-04 | 196 | 269 | 10 | 3533_DN |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | NES ARHGEF11 MAPRE2 GIT1 ASAP3 ADGRL1 NUAK2 ELMO3 GPATCH3 ULK2 | 1.19e-04 | 196 | 269 | 10 | 7187_DN |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | CCNO CHD3 ATG2A MICAL3 PRRC2B MRTFA GPATCH3 ZNF79 EP300 ALG13 | 1.25e-04 | 197 | 269 | 10 | 2837_DN |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A | ATG13 SRCAP ZNF282 GIT1 ASAP3 CCDC85C CGREF1 PLEKHG3 ZNF79 SNAPC2 | 1.25e-04 | 197 | 269 | 10 | 1803_DN |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 269 | 10 | 4730_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | MARS1 BCOR SIK2 PXN MAPRE2 ZNF282 CCDC85C GPATCH3 PLEKHG3 SNAPC2 | 1.25e-04 | 197 | 269 | 10 | 1012_DN |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | CCNO ATG2A FOXG1 NCOA2 ASAP3 CHD7 SLC4A3 PRICKLE3 CGREF1 SMAD3 | 1.25e-04 | 197 | 269 | 10 | 3769_DN |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | ATG13 SRCAP ARHGEF11 AP1B1 PXN GIT1 BICRA CCDC85C ELMO3 GPATCH3 | 1.25e-04 | 197 | 269 | 10 | 3456_DN |
| Drug | HNMPA-(AM)3; Down 200; 5uM; PC3; HG-U133A | 1.25e-04 | 197 | 269 | 10 | 583_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | ATG13 CCNO ARHGEF11 MAPRE2 VEGFB RALGDS HNRNPUL2 ZNF79 ULK2 ALG13 | 1.25e-04 | 197 | 269 | 10 | 7036_UP |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.25e-04 | 197 | 269 | 10 | 4337_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | SPTBN2 NR6A1 SRCAP STOML1 HSF4 FOXG1 VEGFB NLRX1 HIVEP3 MAPRE3 | 1.30e-04 | 198 | 269 | 10 | 3898_DN |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.30e-04 | 198 | 269 | 10 | 4605_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | SRCAP CDR2L PRRC2A MRTFA TCF7L2 NUAK2 HIVEP3 ELMO3 GPATCH3 SNAPC2 | 1.30e-04 | 198 | 269 | 10 | 2392_DN |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.30e-04 | 198 | 269 | 10 | 3196_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | MARS1 ARHGEF11 WIZ MRTFA CCDC85C CD6 PRICKLE3 ZNF79 SNTA1 HR | 1.30e-04 | 198 | 269 | 10 | 4704_DN |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | IRF2BP1 SRCAP WIZ FOXG1 TCF7L2 CCDC85C ADGRL1 CD6 PRICKLE3 SNTA1 | 1.30e-04 | 198 | 269 | 10 | 2281_DN |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | TSPOAP1 CHD3 WIZ FOXO4 PRRC2A MRTFA TCF7L2 GIT1 ZNF335 SMAD3 | 1.30e-04 | 198 | 269 | 10 | 1268_UP |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | KMT2B KIAA0513 ATG13 CHD3 GMIP PRRC2A PRRC2B RALGDS ADGRL1 TACC2 | 1.30e-04 | 198 | 269 | 10 | 7018_UP |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 1.30e-04 | 198 | 269 | 10 | 1690_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | TPRA1 KMT2B CHD3 RALGDS TCF7L2 FRAT1 ADGRL1 MTF1 CGREF1 ZNF79 | 1.30e-04 | 198 | 269 | 10 | 5673_DN |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 198 | 269 | 10 | 3415_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | KIAA0513 MARS1 CHD3 GMIP SRCAP ZNF282 PRRC2A MRTFA RALGDS ADGRL1 | 1.30e-04 | 198 | 269 | 10 | 7035_UP |
| Drug | 2f3r | 1.30e-04 | 9 | 269 | 3 | CID006852180 | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HG-U133A | IRF2BP1 ATG13 SIK2 MRTFA GIT1 ADNP2 ADGRL1 PLEKHG3 ULK2 SMAD3 | 1.35e-04 | 199 | 269 | 10 | 1950_DN |
| Drug | Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | FAM114A1 PIP4K2A MICAL3 VEGFB CCDC85C NUAK2 RGS14 PLEKHG3 EIF4G1 SNAPC2 | 1.35e-04 | 199 | 269 | 10 | 2391_DN |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | PHF1 STOML1 PIP4K2A KCTD15 MICAL3 RALGDS GPATCH3 PRICKLE3 MTOR ZFHX3 | 1.35e-04 | 199 | 269 | 10 | 5789_DN |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A | PCDH12 CDR2L VEGFB RALGDS ANK2 PPFIBP2 RGS14 SNAPC2 STAG3 SMAD3 | 1.35e-04 | 199 | 269 | 10 | 2402_DN |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | IRF2BP1 SRCAP WIZ PXN ZNF282 FOXG1 ASAP3 CCDC85C ZNF79 SMAD3 | 1.35e-04 | 199 | 269 | 10 | 6033_DN |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.35e-04 | 199 | 269 | 10 | 3546_UP | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | KMT2B IRF2BP1 SUSD6 SRCAP WIZ PXN CCDC85C HNRNPUL2 MTOR ZNF79 | 1.35e-04 | 199 | 269 | 10 | 7343_DN |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A | MARS1 NR6A1 PAK6 SRCAP ARHGEF11 MRTFA HIVEP3 RGS14 GPATCH3 ZNF79 | 1.35e-04 | 199 | 269 | 10 | 1511_UP |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | IRF2BP1 ATG2A ARHGEF11 PXN PCSK1N MICAL3 ZNF282 PRRC2A ADGRL1 GPATCH3 | 1.35e-04 | 199 | 269 | 10 | 3273_UP |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; HL60; HG-U133A | TPRA1 ATG13 DAB2 ARHGEF11 NEO1 MAPRE2 ANK2 SNTA1 SZRD1 SMAD3 | 1.41e-04 | 200 | 269 | 10 | 1730_UP |
| Drug | GW9662 | 1.44e-04 | 163 | 269 | 9 | CID000644213 | |
| Drug | galangin | 1.52e-04 | 68 | 269 | 6 | ctd:C037032 | |
| Disease | obsolete aging, cognition | 1.40e-07 | 15 | 259 | 5 | EFO_0003925, GO_0007568 | |
| Disease | Neurodevelopmental Disorders | 1.69e-06 | 93 | 259 | 8 | C1535926 | |
| Disease | Colorectal Carcinoma | RPS6KB1 SPTBN2 APC2 OBSCN PAK6 KMT2C KL PKHD1 UQCRC2 RALGDS TCF7L2 ANK2 ASAP3 HIVEP3 EIF4G1 DCHS1 EP300 SMAD3 HR | 1.63e-05 | 702 | 259 | 19 | C0009402 |
| Disease | corneal topography | 5.15e-05 | 109 | 259 | 7 | EFO_0004345 | |
| Disease | alcohol dependence (implicated_via_orthology) | 5.40e-05 | 9 | 259 | 3 | DOID:0050741 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.28e-04 | 215 | 259 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | descending aortic diameter | 1.28e-04 | 88 | 259 | 6 | EFO_0021788 | |
| Disease | chronic musculoskeletal pain | 1.39e-04 | 12 | 259 | 3 | EFO_0022195 | |
| Disease | cortical thickness | CTTNBP2 KMT2B SPTBN2 TRPS1 DUOX1 ZNF469 NEO1 GLIS2 PKHD1 MICAL3 MAPRE2 WNK2 NCOA2 TCF7L2 RALGPS2 TACC2 CHD7 MAPRE3 ADAMTS7 PAM ULK2 INS-IGF2 PLCE1 | 1.40e-04 | 1113 | 259 | 23 | EFO_0004840 |
| Disease | neuroimaging measurement | CTTNBP2 KMT2B TRPS1 PAK6 ARHGEF11 ZNF469 NEO1 PROSER3 GLIS2 PKHD1 MAPRE2 FOXG1 WNK2 TCF7L2 KIF26B RALGPS2 TACC2 CHD7 INS-IGF2 SZRD1 CRTC2 PLCE1 | 2.08e-04 | 1069 | 259 | 22 | EFO_0004346 |
| Disease | neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (implicated_via_orthology) | 2.29e-04 | 3 | 259 | 2 | DOID:0081327 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (implicated_via_orthology) | 2.29e-04 | 3 | 259 | 2 | DOID:2526 (implicated_via_orthology) | |
| Disease | acute megakaryocytic leukemia (is_implicated_in) | 2.29e-04 | 3 | 259 | 2 | DOID:8761 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 2.58e-04 | 100 | 259 | 6 | C0010606 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 2.89e-04 | 66 | 259 | 5 | EFO_0007708 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.36e-04 | 105 | 259 | 6 | DOID:9352 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.44e-04 | 16 | 259 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | phenylketonuria (implicated_via_orthology) | 4.55e-04 | 4 | 259 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Hearing abnormality | 4.55e-04 | 4 | 259 | 2 | C4025860 | |
| Disease | prostate cancer (is_marker_for) | 4.75e-04 | 156 | 259 | 7 | DOID:10283 (is_marker_for) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 4.93e-04 | 157 | 259 | 7 | DOID:14330 (implicated_via_orthology) | |
| Disease | Intellectual Disability | APC2 CHD3 PCDH12 KMT2C AP1B1 FOXG1 RALGDS PRRT2 MTF1 MTOR ZNF335 ALG13 | 6.45e-04 | 447 | 259 | 12 | C3714756 |
| Disease | mosaic loss of chromosome Y measurement | 7.05e-04 | 80 | 259 | 5 | EFO_0007783 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 7.54e-04 | 5 | 259 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | cortical surface area measurement | CTTNBP2 ATG13 COLEC12 MFAP2 ZNF469 NEO1 GLIS2 PKHD1 SEMA6A MAPRE2 PRRC2A FOXG1 WNK2 NCOA2 TCF7L2 KIF26B RALGPS2 CHD7 MAPRE3 ADAMTS7 PAM ZFHX3 INS-IGF2 PLCE1 | 8.36e-04 | 1345 | 259 | 24 | EFO_0010736 |
| Disease | progranulin measurement | 9.10e-04 | 22 | 259 | 3 | EFO_0004625 | |
| Disease | neuroimaging measurement, brain volume measurement | CTTNBP2 TRPS1 ARHGEF11 PROSER3 WNK2 TCF7L2 FRAT1 KIF26B MYLK2 | 1.02e-03 | 286 | 259 | 9 | EFO_0004346, EFO_0006930 |
| Disease | contactin-2 measurement | 1.12e-03 | 6 | 259 | 2 | EFO_0008100 | |
| Disease | Metastatic melanoma | 1.30e-03 | 54 | 259 | 4 | C0278883 | |
| Disease | creatinine measurement | OBSCN DAB2 LACTB DUOX1 PKHD1 SLC25A29 BSN MRTFA TCF7L2 SLC52A1 KIF26B ARHGEF18 AR RGS14 SLC6A13 ADAMTS7 ZFHX3 INS-IGF2 SMAD3 | 1.35e-03 | 995 | 259 | 19 | EFO_0004518 |
| Disease | Diffuse Large B-Cell Lymphoma | 1.39e-03 | 55 | 259 | 4 | C0079744 | |
| Disease | Hypermetropia, Myopia | 1.46e-03 | 189 | 259 | 7 | HP_0000540, HP_0000545 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.46e-03 | 189 | 259 | 7 | EFO_0009932 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.47e-03 | 139 | 259 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.51e-03 | 364 | 259 | 10 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | alopecia (is_implicated_in) | 1.57e-03 | 7 | 259 | 2 | DOID:987 (is_implicated_in) | |
| Disease | Dengue Hemorrhagic Fever | 1.57e-03 | 7 | 259 | 2 | EFO_0004227 | |
| Disease | long QT syndrome (is_implicated_in) | 1.57e-03 | 7 | 259 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Tinnitus, wellbeing measurement | 1.60e-03 | 96 | 259 | 5 | EFO_0007869, HP_0000360 | |
| Disease | aortic measurement | 1.77e-03 | 251 | 259 | 8 | EFO_0020865 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.86e-03 | 28 | 259 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | telomere length | PRR20C PRR20D PRR20B PRR20E NAF1 PRRC2A PRR20A HIVEP3 ARRDC2 | 1.90e-03 | 313 | 259 | 9 | EFO_0004505 |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.92e-03 | 60 | 259 | 4 | C4722327 | |
| Disease | gestational diabetes (is_implicated_in) | 2.08e-03 | 8 | 259 | 2 | DOID:11714 (is_implicated_in) | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 2.65e-03 | 9 | 259 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.65e-03 | 9 | 259 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 2.65e-03 | 9 | 259 | 2 | cv:C0376358 | |
| Disease | pulse pressure measurement | RPS6KB1 INSR TRPS1 GPATCH8 SRCAP LACTB TTBK1 PIP4K2A CFDP1 BAG6 BICC1 TCF7L2 ANK2 WWP2 RALGPS2 PLCD3 HIVEP3 TBX18 SLC6A13 MTF1 ZFHX3 SMAD3 PLCE1 | 2.85e-03 | 1392 | 259 | 23 | EFO_0005763 |
| Disease | Prostate cancer, familial | 3.21e-03 | 69 | 259 | 4 | C2931456 | |
| Disease | epilepsy (implicated_via_orthology) | 3.26e-03 | 163 | 259 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 3.30e-03 | 10 | 259 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | prostate adenocarcinoma (is_marker_for) | 3.30e-03 | 10 | 259 | 2 | DOID:2526 (is_marker_for) | |
| Disease | prostate cancer (is_implicated_in) | 3.78e-03 | 117 | 259 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 4.00e-03 | 170 | 259 | 6 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | sleep disorder (implicated_via_orthology) | 4.01e-03 | 11 | 259 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | body fat percentage | TRPS1 PKHD1 PRRC2A PRRC2B TCF7L2 MIB2 HIVEP3 ZFHX3 SMAD3 PLCE1 HR | 4.14e-03 | 488 | 259 | 11 | EFO_0007800 |
| Disease | colorectal cancer (is_implicated_in) | 4.36e-03 | 121 | 259 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | metabolite measurement, body weight gain | 4.78e-03 | 12 | 259 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | diverticular disease | 5.01e-03 | 236 | 259 | 7 | EFO_0009959 | |
| Disease | clinical treatment | 5.57e-03 | 41 | 259 | 3 | EFO_0007056 | |
| Disease | Skin Abnormalities | 5.62e-03 | 13 | 259 | 2 | C0037268 | |
| Disease | hypothyroidism (implicated_via_orthology) | 5.62e-03 | 13 | 259 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | prostate carcinoma | CHD3 GPATCH8 PKHD1 SIK2 BSN TCF7L2 ANK2 PPFIBP2 PPP1R13B CHD7 AR ZNF341 ZFHX3 MAP2K1 SPEN CRTC2 | 5.71e-03 | 891 | 259 | 16 | EFO_0001663 |
| Disease | response to selective serotonin reuptake inhibitor | 5.94e-03 | 82 | 259 | 4 | EFO_0005658 | |
| Disease | post-traumatic stress disorder symptom measurement | 5.94e-03 | 82 | 259 | 4 | EFO_0008535 | |
| Disease | basophil percentage of granulocytes | 6.20e-03 | 83 | 259 | 4 | EFO_0007995 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 6.37e-03 | 43 | 259 | 3 | DOID:9261 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.46e-03 | 447 | 259 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | Global developmental delay | 6.48e-03 | 133 | 259 | 5 | C0557874 | |
| Disease | dystonia (is_implicated_in) | 6.51e-03 | 14 | 259 | 2 | DOID:543 (is_implicated_in) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 6.51e-03 | 14 | 259 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 6.51e-03 | 14 | 259 | 2 | DOID:7474 (is_marker_for) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 6.51e-03 | 14 | 259 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | multiple sclerosis | TSPOAP1 RPS6KB1 IL20RA CCDC88B COG6 ESPN NCOA2 SLC52A1 APOA5 RGS14 CD6 ZFHX3 | 6.60e-03 | 594 | 259 | 12 | MONDO_0005301 |
| Disease | high grade glioma (implicated_via_orthology) | 6.79e-03 | 44 | 259 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 6.82e-03 | 190 | 259 | 6 | C0020538 | |
| Disease | Germ Cell Cancer | 7.47e-03 | 15 | 259 | 2 | C0740345 | |
| Disease | Alopecia, Male Pattern | 7.47e-03 | 15 | 259 | 2 | C4083212 | |
| Disease | Embryonal Neoplasm | 7.47e-03 | 15 | 259 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 7.47e-03 | 15 | 259 | 2 | C0027658 | |
| Disease | hepatoblastoma (is_marker_for) | 7.47e-03 | 15 | 259 | 2 | DOID:687 (is_marker_for) | |
| Disease | Autosomal recessive primary microcephaly | 7.47e-03 | 15 | 259 | 2 | cv:C3711387 | |
| Disease | Germ cell tumor | 7.47e-03 | 15 | 259 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 7.47e-03 | 15 | 259 | 2 | C0205852 | |
| Disease | Androgenetic Alopecia | 7.47e-03 | 15 | 259 | 2 | C0162311 | |
| Disease | Cancer, Embryonal | 7.47e-03 | 15 | 259 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 7.47e-03 | 15 | 259 | 2 | C0751365 | |
| Disease | Female pattern alopecia (disorder) | 7.47e-03 | 15 | 259 | 2 | C0263477 | |
| Disease | Neoplastic Cell Transformation | 7.78e-03 | 139 | 259 | 5 | C0007621 | |
| Disease | ascending aortic diameter | 8.01e-03 | 140 | 259 | 5 | EFO_0021787 | |
| Disease | Romano-Ward Syndrome | 8.49e-03 | 16 | 259 | 2 | C0035828 | |
| Disease | central nervous system disease (implicated_via_orthology) | 8.49e-03 | 16 | 259 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 8.49e-03 | 16 | 259 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | body mass index, type 2 diabetes mellitus | 8.49e-03 | 16 | 259 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | filaggrin gene expression measurement | 8.49e-03 | 16 | 259 | 2 | EFO_0020899 | |
| Disease | succinylcarnitine measurement | 8.49e-03 | 16 | 259 | 2 | EFO_0020020 | |
| Disease | Prostatic Neoplasms | CHD3 PAK6 EZH2 KMT2C FAF2 POLK NCOA2 PPFIBP2 CHD7 AR ZFHX3 SPEN | 8.67e-03 | 616 | 259 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | CHD3 PAK6 EZH2 KMT2C FAF2 POLK NCOA2 PPFIBP2 CHD7 AR ZFHX3 SPEN | 8.67e-03 | 616 | 259 | 12 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PIPPFGESEQTPNNL | 36 | A8MT66 | |
| GSAGPEQQQPPLEPD | 406 | Q8N350 | |
| IAGPAANSLPPIVDP | 1601 | Q09472 | |
| EGPPSPRNQPNTALL | 881 | P48751 | |
| QQSPATLPLALPGAP | 841 | P55198 | |
| GALPPDTLAEAQPPS | 1151 | Q6ZSZ5 | |
| VNPPDSPETESPLQG | 411 | O75143 | |
| PSQAPPNSEEGLREP | 811 | Q8TDY4 | |
| LAPLTQAPEADDPQP | 276 | Q86X02 | |
| QQQPAAEPPPAEGLL | 21 | P55884 | |
| ALDVGETSNLQPPPP | 946 | Q9NP73 | |
| DLDIQPGPDPPNSIS | 381 | P0C6C1 | |
| PPPDLQTLGFDPLSE | 116 | A6NC98 | |
| SPLPGPAQPVAQLDL | 81 | P22674 | |
| ERAPAQNPELTPGPA | 241 | P46379 | |
| SGQLQPNLPPDLRAP | 276 | Q8WW27 | |
| INPASLPPGDPQLIA | 26 | Q8IYS8 | |
| AINQLGPDLPPATAP | 446 | O94910 | |
| NLSEAVGSPLPEPPE | 26 | P49640 | |
| PDSLPAGQTEPQPQL | 1386 | O15085 | |
| APAQPIEPITAAPSG | 396 | Q9BZP6 | |
| PPVGEPPALENSTAL | 171 | Q7L190 | |
| AQPELQEPQPAAPGT | 446 | Q6P1R4 | |
| PESRVFSLQQPPPGE | 471 | P19021 | |
| ETEEVQQQLAPPPPG | 306 | Q6Q788 | |
| PPEPGAPVDFQLLTQ | 721 | Q9Y2X7 | |
| SLVQAQQVPDPSGPP | 691 | O94989 | |
| APPTAAVPANLGAPI | 681 | Q10567 | |
| LEQPPNGSDTPNPEK | 696 | Q9UHI6 | |
| EPGEPLAPSPQEPQA | 151 | Q99674 | |
| PGTTPPQDAAQDPNL | 381 | P80365 | |
| PQDAAQDPNLSPGPS | 386 | P80365 | |
| NPEPSFKANENGLPP | 621 | Q6W2J9 | |
| LPIAGILQPVPDPNS | 211 | Q9H694 | |
| NIPSPGQLDPDTRIP | 2556 | Q9P2D1 | |
| DGSPVVLPNSQPDLP | 1371 | A7MBM2 | |
| NDQAEPLPGLEEKPP | 971 | Q9BXF3 | |
| PEPPPTGELQDSILA | 651 | Q8IWY9 | |
| SQLPTPQLANPEPGD | 331 | Q9HA90 | |
| PQLANPEPGDKSNEP | 336 | Q9HA90 | |
| GAPENLQPPPAATEL | 326 | A6NDY2 | |
| NGNLEELPPAQPTAP | 766 | Q96KQ4 | |
| PNLPCSVTLQPGPED | 121 | P49407 | |
| EAALGQSPFPLPQDP | 351 | Q8TBH0 | |
| GAVAEPLSPDPLTNP | 341 | Q2TAZ0 | |
| TQPLAPSLAEAGPPA | 1391 | Q9UKP4 | |
| QGSVPAPLALPSDPQ | 276 | O43918 | |
| QPPILNADAAPGPEK | 996 | Q6IQ32 | |
| PTPIQLNPAPDGSAV | 6 | Q02750 | |
| NLPPSGPPAVVNIAL | 351 | Q9NW64 | |
| LDLLQNPNSPPTGIP | 416 | Q9H8K7 | |
| AAPAGAPPQPQDLEF | 26 | P22695 | |
| LVNRPPPGAPDVLEQ | 191 | O94810 | |
| PFEGPNENPEAELPL | 666 | O95153 | |
| DLPPNKDSPSGQEPA | 721 | P49796 | |
| PPAQDLSPCQDLPAG | 771 | P49796 | |
| TQLSPGAPPQAPDLL | 26 | Q8IVL6 | |
| ENLNLPEPQPATGQP | 861 | Q9NPG4 | |
| SSPLEAPPPVLQDGD | 21 | O60268 | |
| ENPPPIVLPSDGFQV | 771 | Q96JH8 | |
| LPTAPPPLNEGESLV | 1046 | Q01484 | |
| AEAASQLAPPTPELP | 91 | P30203 | |
| LEQPPNLELAGTQPA | 596 | P30203 | |
| PLGEPHLPNPRDLSN | 66 | Q9NRD9 | |
| SPTGQPTALQPNPLD | 471 | P98082 | |
| GAPENLQPPPAATEL | 326 | A8MXZ1 | |
| APEDTVLLPPNTAPG | 896 | Q96JQ0 | |
| PEPQSPRVLPNGLAA | 161 | Q9NQU5 | |
| PAAPAGLQLPQEIPF | 81 | Q02779 | |
| TEGPQLPPVPAATQE | 1176 | Q7RTP6 | |
| NQPGPLPEAALQPQE | 171 | Q8NDB6 | |
| IGPVTDDPSSLPQPN | 1461 | Q8NEZ4 | |
| AAGQPDPRPTQDPAA | 726 | Q8IVU1 | |
| SPLPGAQPQQEPLAL | 61 | Q96FI4 | |
| LDPDSQPPVLASDPG | 791 | Q9P107 | |
| GAPENLQPPPAATEL | 326 | Q86YD7 | |
| PLNQPAAFPAGLPDE | 1626 | Q2KJY2 | |
| PCPDSGEQLQPAPVL | 571 | Q4FZB7 | |
| ASPLAEPPQEQSLAP | 76 | P83111 | |
| IGQPAFQPDSPLPSV | 681 | B1AK53 | |
| PPEEAHLPLAGQASP | 2901 | Q9UPA5 | |
| PKAPEQEQAAPGPAA | 101 | P80723 | |
| DSLQNGPACPAPELP | 321 | A6NKD9 | |
| CGLPPDVPNAQPALE | 36 | P08174 | |
| GPDPAFPRDSQNPLL | 206 | Q9NRD8 | |
| QPRPPGPADVAQLLA | 731 | Q86UP0 | |
| QREVPQGPSPLAVDP | 711 | Q5VYM1 | |
| QNPCPLFLGQPDTVP | 261 | O43593 | |
| GAPENLQPPPAATEL | 326 | A8MWA6 | |
| GAPENLQPPPAATEL | 326 | P0C7W9 | |
| APPQAAPNSALIPTD | 56 | Q96I76 | |
| QPGPVESSLLPIAPD | 1261 | Q9UKJ3 | |
| QLPGALPPECTPNID | 251 | Q15910 | |
| APQPPQTRGAPAADD | 81 | P55316 | |
| NGDLNLQVAPPPPSA | 676 | Q9H1B7 | |
| DPAALAAQLVPAPVP | 146 | Q9UHG2 | |
| PEPELNAAIPSANPA | 526 | Q8WUM4 | |
| PPPPADVLGDAALQR | 126 | Q8N8D1 | |
| ANQPSEPPEVEPDLG | 41 | P98177 | |
| AGPPAALPQQTATPE | 91 | Q9H1R3 | |
| PLALQNEPTPAPEDN | 591 | Q5KU26 | |
| QALGQAAQPPPEPPE | 101 | Q1KMD3 | |
| SPEPNQQPEAGTPSL | 136 | Q9BYJ0 | |
| APAVAPGSLPLLDPN | 116 | Q86XN8 | |
| PSPAQAAETPALELP | 556 | Q8WX92 | |
| FPAQPPVEELGQEQP | 446 | Q8N8W4 | |
| TPILEDAPGPQPQAE | 1226 | P48681 | |
| EASAPLPIRQPNSGP | 491 | P23443 | |
| LRVNADEPPGPPEQV | 241 | Q96QE4 | |
| KNQTAEPLAPEPPAG | 141 | A6NEY3 | |
| KNQTAEPLAPEPPAG | 141 | A6NEF3 | |
| KNQTAEPLAPQPPAG | 141 | A6NEM1 | |
| KNQTAEPLAPEPPAG | 141 | A6NI86 | |
| KNQTAEPLAPEPPAG | 141 | H0YKK7 | |
| NLDLPPSAPGEAPAA | 926 | Q96RT7 | |
| NAPGIPDALPQSPFD | 46 | Q6ZNW5 | |
| SPIQNLDPPLRPDSG | 1836 | Q9UMN6 | |
| NSALEPAPEGPHQVP | 86 | A6NGR9 | |
| ASKGLPQQLPAPPDE | 141 | P10275 | |
| EAENNPGRPPPTLQE | 1121 | P06213 | |
| GSAALLLPPPDQPAE | 731 | Q9HCN3 | |
| GAPENLQPPPAATEL | 326 | P0DV74 | |
| GDLPPVPSASDFQPL | 106 | Q9BZE0 | |
| PPAELALEHQPPQAG | 126 | Q86UT6 | |
| ALEHQPPQAGLPPLA | 131 | Q86UT6 | |
| LENVPASPKPPNLGD | 461 | Q8WWR8 | |
| GAPENLQPPPAATEL | 326 | P0DV73 | |
| DPQPSGNLRPPQEEE | 341 | Q9UHF4 | |
| DGNQPFPVLEPKDSP | 401 | Q8ND30 | |
| VAQPELGFQEPPAAP | 156 | P86480 | |
| PIQDDSNSGAREPPP | 296 | Q75N03 | |
| APQPSLPPEAAQEGD | 4721 | Q5VST9 | |
| PPPSSEALNGTILDP | 51 | P49023 | |
| VAQPELGFQEPPAAP | 156 | P86496 | |
| VAQPELGFQEPPAAP | 156 | P86481 | |
| PESPGQPNLRPDDSA | 451 | O43900 | |
| PPQPAAAPEGQDLRD | 146 | Q96HA1 | |
| GAPENLQPPPAATEL | 326 | A6NJQ4 | |
| PLQSAPPNPNREVAG | 376 | O94856 | |
| QVLAGVPDQPEAPQP | 36 | Q7Z6L0 | |
| EAPQPGPNTTAAPVD | 46 | Q7Z6L0 | |
| LPPPDLGPSSALNQT | 431 | Q9Y2V7 | |
| PSNRPLNELLTPQGP | 171 | P10398 | |
| LAPAPQGPPEATQFS | 1216 | O95996 | |
| QQPAVPAPPAGELIQ | 56 | O43313 | |
| PAPPAGELIQPSVSE | 61 | O43313 | |
| PQANVPSALPSLPAG | 201 | Q9UEE9 | |
| QAPGGPELLPEEPNQ | 1081 | Q711Q0 | |
| EKEPAPLPPSQNSFG | 86 | Q0VDD7 | |
| QGPAAAPALDTLPAP | 366 | Q9P218 | |
| PAFPPPSANKIEENG | 371 | Q8WZ74 | |
| GAAEPEPQSLPPSNL | 586 | Q96PV7 | |
| PVAVPAPQQADGNPD | 521 | Q12873 | |
| QLDTEQPPRLPGSDP | 161 | Q8NFW5 | |
| EVPGINIFPSPDQPA | 246 | Q53ET0 | |
| PPEGPPVLSLQQLEA | 251 | Q8IYS4 | |
| QPSGPECLPLPEANA | 16 | Q7Z7H3 | |
| GASPPTLESLPEQLP | 581 | Q96BJ8 | |
| DPSPEAAPPQAGCLQ | 236 | Q99062 | |
| PTAQPEELLNGAPSP | 396 | Q04637 | |
| EAVPAAPAGPALAQP | 286 | Q8N8R3 | |
| PLGAQTPRATQPPDL | 46 | Q8N5U1 | |
| PAPELQQAPEPAVGL | 311 | Q12967 | |
| NAQQPEPGDPREIPD | 346 | Q9ULV5 | |
| LLQPPQESVEPAGPL | 381 | Q9ULV5 | |
| QDAIPPPDPGEQIFN | 176 | Q15555 | |
| PLLARQGQDVAPPPN | 126 | Q9UPY8 | |
| PPAGQTQSNADALPP | 81 | Q6UWN5 | |
| DALPNLSQAPDPPTL | 116 | Q6UWN5 | |
| PEAENNPGLPQPALG | 1076 | P14616 | |
| GPSALSPLPPQADLD | 136 | Q92837 | |
| PNLAPASPGPAQLQL | 171 | Q6NY19 | |
| NASLPLGAPSPLQPA | 106 | Q9UEF7 | |
| SQPDSQEGPFLPEQP | 241 | Q5JT82 | |
| GENLSKPPSDPEANP | 376 | Q96QF7 | |
| GEEPPPAPNLVAQEN | 236 | Q9BSE4 | |
| PQLEPEPQIPSGQLD | 141 | Q9NT22 | |
| ALEPAPAAGSSPQPL | 391 | Q66K89 | |
| GAPENLQPPPAATEL | 326 | A6NIJ5 | |
| LNPEPNQPAPSVDLD | 61 | Q9NZM4 | |
| GAPENLQPPPAATEL | 326 | A8MXJ8 | |
| PPDLPGAPSNLVISN | 1066 | Q7Z5N4 | |
| LGPEPAAPQQPTAEE | 31 | P37088 | |
| GQIPNTPLPENPCDF | 651 | Q9UJQ4 | |
| ELANVAGLTPPATPP | 1221 | Q5VV67 | |
| QPDSSEQPPPLNGQL | 371 | Q5T953 | |
| GAPENLQPPPAATEL | 326 | P0C7X0 | |
| AAAAAQGPQLPPPQA | 81 | Q8IU81 | |
| QGSESLPAQPPAQPA | 156 | F8WCM5 | |
| QQEVIPAPTPEPGNA | 71 | P55001 | |
| LNSSPPLAPGEFDPN | 321 | P48426 | |
| PSGPLASEQDAPLPE | 56 | Q3KNS1 | |
| TPQAPNPSLSEGEIP | 506 | Q8WUT4 | |
| IGPPVQPQDANALEP | 66 | Q8IWE2 | |
| VLGPHASEPQLAPPA | 261 | O96013 | |
| VAAEGALLPQTPPSP | 316 | Q86X27 | |
| PAPGPPRQLVEELQS | 886 | Q96AX9 | |
| QPPPAQAEGAFPNLA | 161 | Q9BTL4 | |
| LDNPTPFPNLGPSEN | 176 | Q14653 | |
| PDPDPNPGVINNVLA | 786 | P42345 | |
| ELGPPSAVRNQPEPQ | 386 | O43189 | |
| ALPPPPRNGFCQDEL | 26 | Q15406 | |
| VPPQGEDNLLSLPFP | 86 | Q9UBD0 | |
| TSNDQVPIAEGPAPP | 211 | Q14D33 | |
| VIQDDSLPAGPPPQI | 46 | Q7Z422 | |
| TPPDEQGQGDAPPQL | 46 | Q93008 | |
| QLQPAPLEPLGSPDA | 11 | O95219 | |
| ADVNGLPPPSAQFPR | 711 | P0C7P3 | |
| PEPGAPREQEPAQLN | 51 | Q13424 | |
| LNSGPPDCDPNLENP | 1546 | P35499 | |
| ESEVNAIANPPNPLP | 1131 | Q9P212 | |
| EAAQSPGPLPQSKPD | 1111 | A1L390 | |
| AAFGNPPALLQPPEV | 456 | Q14872 | |
| GAPENLQPPPAATEL | 326 | A8MX19 | |
| LRAQPGTPQDSPLPA | 481 | O15353 | |
| GAPENLQPPPAATEL | 326 | A6NNJ1 | |
| GAPENLQPPPAATEL | 326 | P0C7W8 | |
| LNEQEGVPSVFNPPP | 51 | Q96CS3 | |
| PEGPSDPPALLSTLN | 86 | Q8TDN2 | |
| EQPAQPALPIQPEGT | 136 | Q8N4L2 | |
| VAQPELGFQEPPAAP | 156 | P86479 | |
| ETQPEVQLPGPAPNL | 531 | Q92859 | |
| IVFQPPSQALPGDPA | 216 | Q7Z5V6 | |
| SQLPVVNFGSLPPAP | 1986 | P48634 | |
| VAQPELGFQEPPAAP | 156 | P86478 | |
| PNELPFIPPGASEEL | 611 | Q8IUH8 | |
| IPGSPEEASVPNPDL | 171 | Q6UWV7 | |
| PEADPNLAPAAPQLQ | 626 | Q9H0K1 | |
| LGPRAPASPAPAQAQ | 251 | Q2NL68 | |
| PLEPQQPEAPSGASE | 271 | B7ZBB8 | |
| RAPGQEPPADLAPLA | 291 | O95785 | |
| FGDLQPPPANSPVLV | 671 | P08F94 | |
| TLPAPQIPDAGAPTV | 1251 | P08F94 | |
| LPQQPPPSLEDAGQQ | 416 | Q14160 | |
| LAQAHPAGPPTLDPV | 971 | Q15477 | |
| PAGPPTLDPVNDLQL | 976 | Q15477 | |
| APAPGQVQDIQPALP | 546 | P07476 | |
| GVQEDPPELSPIPAS | 421 | Q9H093 | |
| PTGLSLPLAANQVPP | 1286 | Q6ZRS2 | |
| SAPNPAPAQASLLAP | 1561 | Q6ZRS2 | |
| DGLASVCPLPPEPEN | 36 | Q92537 | |
| DFNSQLAPGVDPSPP | 121 | A6NHP3 | |
| GAPENLQPPPAATEL | 326 | P0C7V4 | |
| PLAAQPSPSAELPQA | 786 | Q969V6 | |
| QLPAGPQESAAEPTP | 331 | Q9BWE0 | |
| NVTLLNPDPAEGPKP | 246 | Q8WZ75 | |
| PGEQKETNDPNLPPA | 606 | Q15596 | |
| PTQLAALPAPEEAGP | 321 | Q6PCB0 | |
| SPVSLNVVNGDPPAP | 476 | Q32MQ0 | |
| NLEAELGPSPPAPDV | 286 | Q9UID3 | |
| VNDNPDPAPLSPELQ | 206 | Q9UHF7 | |
| NGSTALPPPLAPNIS | 11 | Q86W33 | |
| QPPDVILEPNVTPGN | 236 | Q8TC36 | |
| QLPAAAQAPDALPAG | 291 | O00308 | |
| PDPTGQSVNAPPAIQ | 31 | Q9BYN7 | |
| QPLPGAPQPQALSTA | 411 | Q9BYN7 | |
| DQENAPPILPGRPSE | 366 | Q5TCY1 | |
| PEAAPSTQLGEVPAP | 366 | Q96K62 | |
| PPAPTGQDDPQSQLL | 486 | Q9BSA9 | |
| PAPVEQLEQVDLPPG | 1691 | Q96T58 | |
| AQSLPGAPPPFDAQI | 71 | Q9UHK0 | |
| LPGAQPPFDAQSPLD | 86 | Q9UHK0 | |
| PGSQPQALAEPAALA | 126 | Q96EK2 | |
| LPDASPGNLEQPPDN | 651 | O15027 | |
| ATLPPRGPEPSAQEQ | 2206 | O15020 | |
| LSELPPAGSSNQPPN | 991 | Q9UJ98 | |
| LPLQEPPSQAAGTIP | 251 | Q9NWF4 | |
| AVLQPPQDSPAGPNL | 221 | Q9UBI4 | |
| PVSPLAAQGIPLPAQ | 36 | Q96SI1 | |
| SPNPEELPSPEQLKG | 461 | Q8N3E9 | |
| TPLPSPQAPRVDLQG | 131 | O95935 | |
| FPAGIEPQSNIPETP | 166 | P84022 | |
| DFNSQLAPGVDPSPP | 81 | A6NNV3 | |
| DFNSQLAPGVDPSPP | 121 | P0DV79 | |
| DFNSQLAPGVDPSPP | 121 | A0A494C086 | |
| DFNSQLAPGVDPSPP | 121 | Q495Y8 | |
| DFNSQLAPGVDPSPP | 121 | P0CI01 | |
| GDNPPPAPQRVDSIQ | 956 | Q9H2E6 | |
| AEDLPQRNPAGPSAP | 571 | Q9NSD5 | |
| APPLDAQGNIQPPAS | 191 | A6NCN8 | |
| DFNSQLAPGVDPSPP | 81 | Q8NFV5 | |
| EPVLGQEQPAAPDQP | 616 | Q9C0C2 | |
| GALDLPPAALQPAAP | 571 | Q9NQB0 | |
| ALENLQPPPAATELG | 326 | Q658T7 | |
| SPSDVQPPGDPFQVN | 256 | Q9UBT6 | |
| QELLAPQPFPGPSSV | 51 | Q5T1R4 | |
| CPQAPPLEPGAQALA | 131 | Q9H8N7 | |
| ATASQPPESLPQPGL | 101 | Q5JSZ5 | |
| APPGINLVAPPSSQL | 86 | P48443 | |
| RDLGNPNTAPPTPEL | 911 | P78364 | |
| ESPCPVGEPPLALEN | 1266 | O95359 | |
| LQLPAQGPSSEETPP | 531 | O43566 | |
| VANPVPGANPDLLPH | 31 | Q6ZN44 | |
| PPARQPGEFLAPVAN | 1291 | Q96JG9 | |
| LAPAQAPVSQPDAPG | 16 | P49765 | |
| IQEENLSSPPLGPPN | 316 | Q8IYT8 | |
| DFNSQLAPGVDPSPP | 81 | A6NJR5 | |
| TIDTPLPGQAPPEAE | 236 | Q9BSL1 | |
| QPHLPEQAAPAATPG | 1006 | Q9Y3S1 | |
| ASALAPAPPQVLPQA | 376 | Q04206 | |
| PVQLPPASGAEEPDL | 216 | Q9H4Z2 | |
| DPRPPNGQSPIALAS | 96 | Q6BDS2 | |
| VLPSPGPALPQEENT | 6 | Q15937 | |
| PQPSPAEGRAVTNEP | 206 | P56192 | |
| EALPQGSPAPVQDPH | 6 | Q9H347 | |
| ENPGLTSPEPQLPNS | 231 | A6NGD5 | |
| PLLLSAPGGQEDPAP | 151 | Q13487 | |
| EPDRALQTSPQPPEG | 956 | Q6PFW1 | |
| QPQSLPPIAVAENPG | 426 | Q9UDV7 | |
| PQLGPVEPLPADLAQ | 2116 | Q15911 | |
| DPQGTPVSTQDLPPQ | 351 | Q70EL1 | |
| PQEPPIPESLAAAAA | 146 | Q9NQZ6 | |
| ASPIPGAPPENITNV | 326 | Q14003 | |
| DLANVSGFPPIPTQP | 271 | Q9UQQ1 | |
| LNAVAAGTPAPQPQP | 71 | Q96HR8 | |
| EVAAPEPLPADGQSP | 541 | Q96BF6 | |
| EPLPADGQSPPQPFE | 546 | Q96BF6 |